The Cannabis Investing Podcast: Recent Episodes
Seeking Alpha
On The Cannabis Investing Podcast, host Rena Sherbill provides actionable investment insight and the context with which to understand the burgeoning cannabis industry. Interviews with C-level executives, analysts and sector experts give you investment ideas to consider, help you think through your investing approach and give you a new lens with which to understand this ever-growing sector.
Josh Rosen and Jerry Derevyanny from Bengal Capital discuss the current state of cannabis investing (1:10). Trump takes action to reschedule cannabis; federal regulations and investment strategies (6:30). Challenges of valuation in the cannabis sector (19:00). Expected consolidation in the industry; insights for retail investors (23:20). Is there a first mover advantage? (26:30). Understanding 280E (30:00). Deep dive on Glass House (GLASF) (32:20). More on valuation (38:10). Public vs. private, hemp, ETFs (46:00).
Episode transcripts
For full access to analyst ratings, stock quant scores and dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions
Cannabis expert Jesse Redmond shares why he's now at LEEF Brands (1:30). Excited about New York's evolution (8:15). How and why it got so bad in the industry (16:00). Are we early or are we wrong? (22:05) Who may survive and get to the finish line (28:35). Intoxicating hemp market (32:40).
Episode transcripts
Show Notes:
Cannabis REITs: Less Risky Choices In A Risky Sector
Green Thumb Stands Alone. Billions In Debt Coming For MSOs
Leef Brands
For full access to analyst ratings, stock quant scores and dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions
Julian Lin updates his views on cannabis REITs IIPR and NewLake Capital (1:15). RIP Cannabis Growth Investor - changed thesis on cannabis MSOs (6:45). Why Green Thumb has done well relative to the sector (13:35).
Episode transcripts
Show Notes:
NewLake Capital: 9.3% Dividend Yield, No Net Debt, Rescheduling Catalyst
Marijuana rescheduling "delayed, but not dead": report
Best Of Breed Growth Stocks
For full access to analyst ratings, stock quant scores and dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions
High Tide is the largest cannabis retailer in Canada (1:20). President and CEO Raj Grover joins us to discuss its recent move into Germany (3:15). Purecan acquisition - a beautiful business to buy (8:00). Tilray is complementary, not competition (14:00). No hurry to get into the US (18:00). Contextualizing valuation and revisions (20:35).
Read episode transcripts
Show Notes:
High Tide outlines 2025 plans: 20-30 new stores and German market expansion
High Tide Q4 2024 Earnings Call Transcript
Cannabis In Germany - Legalize, Don't Decriminalize
High Tide website
For full access to analyst ratings, stock quant scores and dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions
Why 2025 will be interesting and perhaps painful for the cannabis industry, according to Seth Yakatan (2:00). Enormous looming debt for many companies (5:15). GTI the only company consistently delivering year-in and year-out (8:30). TerrAscend, Ascend and the 2nd tier of MSOs (12:00). Glass House seemingly winning its bet on scalability (19:15). Which private companies have some of the best assets in the industry (28:10). MSOS, MSOX and cannabis ETFs (35:25).
Read episode transcripts
Show Notes:
Tremendous Opportunity In Cannabis
Green Thumb Industries Virtual Analyst Report
For full access to analyst ratings, stock quant scores and dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions
CannaVestments and Jerry Derevyanny return for an in-depth episode. Dissecting doom and gloom Q3 earnings for the cannabis industry (0:50). Green Thumb's consistently outstanding performance (4:25). Is it too early or too late to invest in cannabis? (11:15) Florida not legalizing - how much does it matter? (17:30) Agrify's interesting moves (35:40). Hemp, beverages and what may be worthy of investors' attention (40:00). Glass House discussion (47:40). Shorting Curaleaf? (53:55)
Read episode transcript
Show Notes:
Bengal Capital - Grown Rogue: Remains Materially Undervalued, Best Days Still Ahead
Cannabis Investors - What You Should Know
How Retail Investors Should Evaluate Cannabis Stocks
Tremendous Opportunity In Cannabis
Black Friday Sale: 20% Off Seeking Alpha. Find the right investment tools to reach your goals!
Grown Rogue has been lauded by a number of analysts on this show so we decided to talk to VP Jake Iotte about what makes the company stand out and whether cannabis belongs in the CPG industry (1:30). Margins and ROI profile; focused on cash on cash returns (4:20). Excited about Jersey (7:10). Terminating partnership with Vireo (8:25). Not relying on federal legalization as a strategy (10:50).
Read episode transcripts
Show Notes:
Bengal Capital - Grown Rogue: Remains Materially Undervalued, Best Days Still Ahead
Cannabis Investors - What You Should Know
Grown Rogue: Poised For Explosive Growth
For full access to analyst ratings, stock quant scores and dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions
Jesse Redmond highlights the fine line between being early and wrong and why having a long-term timeline is wise for cannabis investors (2:10). Why Florida is a massive opportunity (9:35). Green Thumb, Verano and pushing for more company transparency (17:50). Pennsylvania a state-led catalyst; solving for the current risks to getting into cannabis (26:05). Farm Bill flower, the hemp conversation, valid excitement over Ohio and Minnesota and Glass House (31:20). Top 3 ways to allocate capital for retail cannabis investors (52:00).
Read episode transcripts
Show Notes:
Trump appears open to decriminalizing marijuana
Ayr CEO David Goubert On Florida, Ohio And 'Very Balanced' Q2
Texas Cannabis, Delta-8 And Delta-9
Glass House's Graham Farrar On Industry Challenges And Opportunities
For full access to analyst ratings, stock quant scores and dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions
Ayr Wellness CEO David Goubert talks 'very balanced' Q2 earnings. (1:15) Focus on state footprints: Florida legalization, Ohio's nice rollout. (6:00) Debt and dilution: progress and strategies. (8:15) Any plans to grow hemp? (21:15) Industry valuations as the market evolves and legalization develops. (23:00) How to establish a national brand and the general cannabis retail picture. (36:00)
Read episode transcripts
Show Notes:
Ayr Wellness CEO David Goubert Focused On Debt And Cash
Cannabis stocks on watch as DEA sets hearing on marijuana rescheduling
Ayr Wellness Q2 2024 Earnings Call Transcript
Florida MSO Trump Card
For full access to analyst ratings, stock quant scores and dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions
Jason Najum has covered the psychedelic space for a long time and contextualizes recent news around the FDA, MDMA, PTSD and Lykos Therapeutics (1:35). Blessing in disguise for Cybin, COMPASS Pathways and MindMed (14:30)? Trial data and cash in the bank are top signifiers of success (22:35). How Atai fell behind and dropped out of the conversation (24:00). Upcoming catalysts - patience required (26:35). For psychedelic medicine, does it matter who's in the White House (29:30)?
Read episode transcripts
Show Notes:
FDA's MDMA Decision A Setback, But Long-Term Outlook For Psychedelic Stocks Unchanged
MindMed: Despite MDMA Setback, Still Hope In Light Of Differentiating Factors
ATAI: Enormous Potential Upside But No Clarity Yet
De-Risking Psychedelics: Compass Pathways, Cybin And Atai
For full access to analyst ratings, stock quant scores and dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions
On June 18 at our Seeking Alpha Investing Summit, Pablo Zuanic, Tim Seymour, and Julian Lin discussed how to best invest in the sector (0:20). Best metrics to use when evaluating cannabis stocks (4:40). At this point in time, what is the best way to get into the sector? (19:00) Rescheduling, the Trump factor, investing in an election year (26:40). Originally published here with video.
Cannabis Growth Portfolio
Show Notes:
NewLake Capital, IIPR And Cannabis REITs
Cannabis ETF Deep Dive
A New Age For Crypto
Marijuana rescheduling proposed rule comments due by July 22
Episode transcripts
For full access to analyst ratings, stock quant scores and dividend grades, become a Premium subscriber: seekingalpha.com/subscriptions
Jerry Derevyanny and Julian Lin breakdown the current state of the cannabis sector (1:00). How companies are massaging their earnings results (3:30). Proper metrics to use as the market develops (7:45). Green Thumb's growth mode and solid margins (16:05). Institutional capital and what will really make the industry soar (21:15). Thoughts on Verano and Goodness Growth (47:25). New states coming online - worthy of excitement? (57:35) NewLake Capital, cannabis REITs and dividend yields (1:08:40).
Show Notes:
How Retail Investors Should Evaluate Cannabis Stocks
What Has Verano So Optimistic About The Cannabis Industry?
MasterClass In Cannabis Investing Redux
My Top Pick: NewLake Capital Yields 12% With Net Cash Balance Sheet And Built-In Growth
Episode transcripts
For full access to analyst ratings, stock quant scores and dividend grades: seekingalpha.com/subscriptions
Register for Seeking Alpha's Investing Summit (don't forget your podcast discount code!)
Alex Carchidi talks why he's bullish on the cannabis sector, but not ready to buy stocks (1:15) except for IIPR (2:15). 2 cannabis stocks worth looking at (7:25). Tilray the only international option (13:30). Who looks good in Canada (16:40). Why Alex avoids MSOS ETF (22:30). Legalization, rescheduling and incremental change (23:20).
Show Notes:
Biden administration reportedly moves to reclassify marijuanaTrulieve Cannabis: Up Over 122% In 2024, But Where Does It Go Next?
What Cannabis Reform In Germany Means For North American Marijuana Companies
Canopy Growth Is Climbing, But It Won't Last
Episode transcripts
For full access to analyst ratings, stock quant scores and dividend grades: seekingalpha.com/subscriptions
Register for Seeking Alpha's Investing Summit (don't forget your podcast discount code!)
Verano (VRNOF) CEO George Archos and CIO Aaron Miles on recent earnings and why they're the most optimistic they've been (0:45). Company transparency like state by state data (7:50) and what metrics they're each focused on (12:05). Why they're so excited about Florida, Ohio and Pennsylvania (14:35). The federal regulation roller coaster (21:05).
Show Notes:
How Retail Investors Should Evaluate Cannabis Stocks
Cannabis Investors - What You Should Know
Verano Holdings Q1 2024 Earnings Call Transcript
White House mum on where Biden stands with marijuana rescheduling
Episode transcripts
For full access to analyst ratings, stock quant scores and dividend grades: seekingalpha.com/subscriptions
Register for Seeking Alpha's Investing Summit (don't forget your podcast discount code!)
Mario Naric, CEO and Founder of Motif Labs, discusses being in the shakeout phase of cannabis in Canada (1:00). Staying private while public companies suffer (5:25). How to grow market share in Canada (12:53). Near-term reality for big Canadian LPs like Tilray and Canopy Growth (18:00). Different products for different markets within US and Canada (23:20). Where should investors allocate their capital in this space? (40:40)
Show Notes:
Oh No, Canada
Cannabis Investing With Alan Brochstein & Julian Lin - REITs And Canadian LPs Over MSOs
DEA to reschedule marijuana as a less dangerous drug: AP
Episode transcripts
For full access to analyst ratings, stock quant scores and dividend grades: seekingalpha.com/subscriptions
Motif Labs
David Hart recently became CEO of The Cannabist Company and is focused on building a strong asset base in the US cannabis market (1:35). Metrics and internal expectations, wholesale business; finding ways to improve margin profile and cash generation (11:25). Is more transparency coming?(14:45) Thoughtful ways of approaching debt (17:10). Industry rallies, price drops and technical overhangs (26:40).
Show Notes:
Cresco Labs, Columbia Care call off merger
How Retail Investors Should Evaluate Cannabis Stocks
The Cannabist Company enters into debt repurchase agreement
Seeking Alpha’s Quant Rating on Cannabist
Episode transcripts
For full access to analyst ratings, stock quant scores and dividend grades: seekingalpha.com/subscriptions
Bengal Capital's Jerry Derevyanny shares his evolving thoughts on 280E and the process of rescheduling cannabis (2:20). Some uncomfortable truths about how investors should be evaluating cannabis stocks (8:30). When will companies become more transparent? (21:40) Who is handling debt well and who isn't (27:15). Examples of sustainable value creation in the industry (34:00).
Episode transcripts
Show Notes:
Bengal Capital FY2023 Letter
Where Is The Value In Cannabis Stocks?
For full access to analyst ratings, stock quant scores and dividend grades: seekingalpha.com/subscriptions
Katie Neer and Hirsh Jain break down the dispiriting New York and California cannabis markets (3:00). What the 2 states have gotten wrong, and why it's not being corrected (9:55). Dysfunction and pushing regulators and the law to work better (34:45). Are there investment opportunities in either market? (47:40)
Episode transcripts
Show Notes:
Unpacking New York And California Cannabis Markets
What's The Deal With New York Cannabis?
California Cannabis Market - Deep Dive, Part II
For full access to analyst ratings, stock quant scores and dividend grades: seekingalpha.com/subscriptions
Cannabis Investing Podcast on Twitter
Katie Neer
Hirsh Jain
Alan Brochstein thinks investors are overly excited about the recent rescheduling announcement, which he says is really no news at all (2:20) Balance sheets, debt, income tax payable and the burden of 280E (4:00) California and New York continuing challenges (23:20) What's right and wrong with Canada (32:30) Broad and specific thoughts on MSOs (38:10).
Subscribe to Alan's 420 Investor
Episode transcripts
Show Notes:
Beaten-Up Planet 13 Is A Solid Cannabis Investment
Trulieve Is Cheap But Perhaps Risky
Curaleaf Is A Bad Cannabis Investment
Why Organigram Is My Favorite Cannabis Stock
Cannabis Investing With Alan Brochstein & Julian Lin - REITs And Canadian LPs Over MSOs
For full access to analyst ratings, stock quant scores and dividend grades: seekingalpha.com/subscriptions
Cannabis Investing Podcast on Twitter
Alex Carchidi updates us on the psychedelic sector and what critical catalysts are approaching (1:30). Why Compass Pathways, Cybin, and Atai make the most sense for investors at this point (15:00). Pros and cons of 4 main industry stocks, including MindMed (29:50).
Episode transcripts
Show Notes:
Psychedelic Stocks = Super-Risky Biotechs Low On Cash. Make Small Bets.
Psychedelic Stocks: Don't Bet On Just 1 Company
Psychedelic Sunday: Scrutinizing Psychedelic Stocks
Cybin: A Leading Early-Stage Psychedelics Play
For full access to analyst ratings, stock quant scores and dividend grades: seekingalpha.com/subscriptions
Cannabis Investing Podcast on Twitter
A rundown of reasons to be hopeful and some compelling advice from some of our favorite 2023 conversations. Why Chris DeMuth likes the opportunity in cannabis (1:20) Julian Lin on M&A, debt and disappointment (10:05) Alan Brochstein: waiting for catalysts while working through tough times (12:20) Jesse Redmond discusses the best way to invest in this space (13:35) Emily Paxhia on SG&A containment, gross margins and using the right metrics (17:20).
Episode Transcripts
For full access to analyst ratings, stock quant scores and dividend grades: seekingalpha.com/subscriptions
Cannabis Investing Podcast on Twitter
Nick Gastevich, aka CannaVestments, talks Q3 cannabis efforts; avoiding dilution, equity raises or adding further debt (2:30). Navigating the industry as a retail investor; companies that protect shareholders (14:00). The future of 280E, catalysts definitely needed (24:00). 7 stocks - what's working, what's not (30:00).
Show Notes:
What Cannabis Stocks Should Be In Your Portfolio?
Searching For Cannabis Catalysts
Cannabis Investors Should Be Looking For Good Stewards Of Capital
Episode Transcripts
For full access to analyst ratings, stock quant scores as well as dividend grades, sign up at https://seekingalpha.com/subscriptions.
CannaVestments on Twitter
Cannabis Investing Podcast on Twitter
TerrAscend's Executive Chairman Jason Wild returns. Focused on not spreading itself too thin ("we'd rather be more focused, spend more money, get more scale, like we did in Jersey") and why not all EBITDA numbers are created equally (8:50). Should cannabis companies pay their taxes? (11:40) Pushing for real legislative change with famed lawyer David Boies (13:30).
Show Notes:
TerrAscend GAAP EPS of -$0.04
Better Margins In Cannabis
Episode Transcripts
For full access to analyst ratings, stock quant scores as well as dividend grades, sign up at https://seekingalpha.com/subscriptions.
Do ETFs make sense for everyone? ETF expert Rob Isbitts discusses his thesis on cannabis ETFs and the importance of understanding their structure and holdings (8:00). The need for a diversified but not overly diversified portfolio and the importance of technical analysis in evaluating ETFs (24:50).
Show Links:
MSOS: An Industry-Wide Catalyst Approaches
A Close Look At 13 Cannabis ETFs
Defying The Odds, ETFMG Alternative Harvest Outperforms Other Cannabis ETFs
Covered Call ETFs And The Limitations Of Stocks
For full access to analyst ratings, stock quant scores as well as dividend grades, sign up at https://seekingalpha.com/subscriptions
Cannabis Investing Podcast on Twitter
Rob Isbitts on Twitter
Chris DeMuth talks about investing in the cannabis industry (1:30) legalization, SAFE banking and whether the investment community cares (9:00) and why he's so bullish on SHF Holdings (14:45).
Subscribe to Chris' Sifting The World
Transcript on Seeking Alpha
Show Notes
Sifting The World Day One
SPAC Week II: Cannabis SPACs
A Close Look At 13 Cannabis ETFs
For full access to analyst ratings, stock quant scores as well as dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions (new subscribers get the 1st month for under $5)
Cannabis Investing Podcast on Twitter
Chris DeMuth on Twitter
Jesse Redmond returns to discuss why it's ok to be bullish on the cannabis industry (4:30) political catalysts, 280E and excise taxes (12:15) picking companies based on your investing horizon (15:00) Green Thumb's dominance and lack of transparency (20:55) AYR's debt strategy (23:10) Trulieve's tough period (21:00) California players (38:00) and TerrAscend's innovation and execution (44:55).
Transcripts on Seeking Alpha
Show Notes:
Who Can Survive In Cannabis?
Cannabis stocks rally amid reports DEA may reclassify drug as less risky
Evaluating Advisor Shares Cannabis ETFs
Where Is The Value In Cannabis Stocks?
Ayr Wellness CEO David Goubert Focused On Debt And Cash
Ascend's Attractive Assets
For full access to analyst ratings, stock quant scores as well as dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions (new subscribers get the 1st month for under $5)
Jesse Redmond on Twitter
Cannabis Investing Podcast on Twitter
Water Tower Research
Emily Paxhia discusses recent positive news for the industry and its accompanying rally (2:00), the long-term play in cannabis, especially for retail investors (6:10), Green Thumb's share repurchase and can any other operator keep up? (13:40) TerrAscend's smart TSX move (16:10) New York, California, Glass House scale, private companies and the Gold Flora deal (18:20) and looking at the right metrics (27:35).
Transcripts on Seeking Alpha
Show Notes:
Where Is The Value In Cannabis Stocks?
Tremendous Opportunity In Cannabis
The Curious Cannabis Industry
California's Cannabis Market - A Deep Dive
California Cannabis Market - Deep Dive, Part II
MSOS: Cannabis Stocks Soar On HHS Recommendation To Reschedule, Buy These 3 Stocks Now
Cannabis stocks extend rally amid positive news on regulatory front
For full access to analyst ratings, stock quant scores as well as dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions (new subscribers get the 1st month for under $5)
Poseidon
Cannabis Investing Podcast on Twitter
Emily Paxhia on Twitter
Alan Brochstein and Julian Lin discuss investing in cannabis stocks and mistakes made along the way (3:00). Why companies should be more aggressive in paying down debt (9:00) Investing timelines and federal legalization (19:00) Cannabis REITs and Canadian LPs over MSOs (23:45).
Subscribe to Julian's Cannabis Growth Investor
Subscribe to Alan's 420 Investor
Show Notes:
Innovative Industrial: Top Cannabis Pick With 9% Dividend Yield
MasterClass In Cannabis Investing Redux
Top Cannabis Picks To Buy And Celebrate 4/20: MSOS And NewLake Capital
Not Necessarily Time To Buy Cannabis Stocks - Alan Brochstein
Organigram Is Still My Favorite Cannabis Stock
Curaleaf Could Fall To $2
Trulieve Offers An Excellent Entry
Transcripts on Seeking Alpha
For full access to analyst ratings, stock quant scores as well as dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions (new subscribers get the 1st month for under $5)
Enosis Therapeutics combines virtual reality with psychedelic psychotherapy protocols. Founders Dr. Prashanth Puspanathan and Agnieszka Sekula discuss why VR makes sense for psychedelic therapy and where capital should really be allocated to in the space.
Episode transcripts can be found on Seeking Alpha
For full access to analyst ratings, stock quant scores and dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions.
Paul Trowe talks about going from crypto to cannabis by founding Herban Bud in Austin, Texas (5:00). Breaking down cannabinoids and legal loopholes: THC, THCA, Delta 8 and Delta 9 (9:25) Texas, cannabis legalization and educating law enforcement and government (14:15). Maintaining integrity in a shady lane of the industry (27:00) Paul's thoughts on Bitcoin and Ethereum and why he's not currently invested in equities (34:15).
Episode transcripts can be found on Seeking Alpha
For full access to analyst ratings, stock quant scores and dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions.
Herban Bud
NORML
Last Prisoner Project
Analyst Alex Carchidi returns to update investors on the psychedelics industry. This is the full conversation of an interview originally published on Investing Experts.
* (2:50) Industry's collapse and consolidation
* (5:00) Compass Pathways timeline for clinical trials
* (15:00) Super-risky biotech companies low on cash - don't bet on just 1 company
* (21:20) Atai and Cybin's recent wins
* (32:55) Ketamine clinics and viable business models
Psychedelic Sunday: Scrutinizing Psychedelic Stocks
Cybin: A Leading Early-Stage Psychedelics Play
Psychedelic Sunday: Mushrooms Are The Key - Red Light Holland CEO Todd Shapiro
Numinus CEO Payton Nyquvest On Transforming Healthcare With Psychedelics
Podcast transcripts on Seeking Alpha
Cannabis Investing Podcast Twitter
Derek Du Chesne and Dr. Sam Zand founded Better U and today discuss getting into ketamine therapy (4:00), psychedelics gaining more legal and medical acceptance (23:00), industry differences between cannabis and psychedelics (27:30) and advice for investing in the space (42:30).
Cannabinoid Consolidation (Derek's previous appearance)
Numinus CEO Payton Nyquvest On Transforming Healthcare With Psychedelics
Podcast transcripts on Seeking Alpha
Cannabis Investing Podcast Twitter
MariMed (MRMD) CEO Jon Levine discusses steady growth and the cannabis retail market.
* (8:30) - Owning real estate and consecutive quarters of positive cash flow
* (12:10) - Maryland, Missouri excitement
* (17:45) - Raising money at relatively decent rates
* (27:30) - Legalization, interstate commerce and future growth
Organic Growth With MariMed
Who Can Survive In Cannabis?
What Cannabis Stocks Should Be In Your Portfolio?
Where Is The Value In Cannabis Stocks?
Tim Seymour On Constructive Pessimism In Cannabis
Podcast transcripts
CIP on Twitter
- (3:00) - Headwaters' Nick Brandis on one of the largest cannabis cultivators you've never heard of
- (8:00) - Why greenhouses will be the winning method in the long run
- (13:15) - Deciphering cannabis pricing volatility and compression
- (40:15) - Partnering with Glass House (GLASF), competition and the illicit market
Our links:
The Cannabis Investing Podcast
The Cannabis Investing Podcast provides actionable investment insight and the context with which to understand the burgeoning cannabis industry. Transcripts available for every episode.
Seeking Alpha Premium
A comprehensive set of features and analysis that helps take the guesswork out of your investing decisions. Get the bottom-line on any stock or ETF with our Premium tools.
Alpha Picks:
Alpha Picks gives you two top stock picks each month, sifted from Seeking Alpha’s analysis of thousands of stocks. We do the work. You reap the rewards.
CanPod on Twitter
Show Notes:
California Cannabis Market - Deep Dive, Part II
Headwaters
Alan Brochstein is back to share his cannabis investing insights.
* (2:50) - 420 Investor's origin story
* (8:30) - Cannabis investing timeline - now is not necessarily the time to buy cannabis stocks
* (17:50) - Ayr's (AYRWF) debt and executive changes
* (24:00) - Tangible book value and how to gauge cannabis stocks
* (29:00) - Planet 13 (PLNHF) a business that's managed well
* (34:40) - Still bullish on WM Technology (MAPS)
Show Notes:
Subscribe to 420 Investor
Looking For The Cheapest Cannabis Stocks
Planet 13 Offers Big Upside And Low Risk For Cannabis Investors
Tilray Is Likely To Fall More
Put WM Technology On Your Cannabis Investing Map
All Cannabis Investing Podcast episodes with transcripts
4Front Ventures' (FFNTF) Brandon Mills joins us to discuss how they're making it work in an incredibly challenging environment. In California, not being vertically integrated, or even partially vertically integrated is a business model that's really tough to sustain (5:00), addressing the multitude of headwinds (11:40), cultivation, gross margins and Glass House (GLASF) (15:00), Illinois growth opportunity (22:00) and balancing debt, growth and profitability (31:00).
Our links:
The Cannabis Investing Podcast
The Cannabis Investing Podcast provides actionable investment insight and the context with which to understand the burgeoning cannabis industry.
Seeking Alpha Premium
A comprehensive set of features and analysis that helps take the guesswork out of your investing decisions. Get the bottom-line on any stock or ETF with our Premium tools.
Alpha Picks:
Alpha Picks gives you two top stock picks each month, sifted from Seeking Alpha’s analysis of thousands of stocks. We do the work. You reap the rewards.
Twitter
Instagram
Show links:
4Front Ventures
4Front Stock Quote page
4Front Ventures Corp. (FFNTF) Q1 2023 Earnings Call Transcript
Psychedelics are being pulled into the mainstream by medical research (9:00). Filament Health CEO Benjamin Lightburn on Psilocybin and why of all the psychedelics it probably lends itself best to a recreational market (15:00). Microdosing clinical trials (19:00) real revenue generation (28:00) and challenges around psychedelic patents (33:30).
Our links:
The Cannabis Investing Podcast
The Cannabis Investing Podcast provides actionable investment insight and the context with which to understand the burgeoning cannabis industry. All transcripts can be found on Seeking Alpha.
Seeking Alpha Premium
A comprehensive set of features and analysis that helps take the guesswork out of your investing decisions. Get the bottom-line on any stock or ETF with our Premium tools.
CanPod on Twitter
Show links:
Filament Health
FLHLF
Outlining the cannabis industry's Haves (companies that have been able to raise capital) and The Have Nots (no ability to raise capital) with Seth Yakatan. The keys to making a deal and raising capital (9:10), Why Seth prefers real EBITDA and revenue to book value (14:00), Glass House, 4Front; California's created tremendous opportunity (24:50), better to be private than public? (38:00) legal and illicit pricing dynamics (1:00:00).
Show Links:
Cannabis Investing Podcast episodes with Transcripts
Katan Associates
Investing Groups:
420 Investor
Cannabis Growth Portfolio
David Goubert, recently minted CEO and President of Ayr Wellness (AYRWF), discuses coming on board (3:00), working through debt, strategizing for positive free cash flow (19:00), pricing, margins and inventory (25:30), integrating acquisitions; updates on Florida and Nevada (33:00).
Our links:
The Cannabis Investing Podcast
The Cannabis Investing Podcast provides actionable investment insight and the context with which to understand the burgeoning cannabis industry.
Seeking Alpha Premium
A comprehensive set of features and analysis that helps take the guesswork out of your investing decisions. Get the bottom-line on any stock or ETF with our Premium tools.
Investing Experts Podcast
Seeking Alpha investing experts provide deep dive stock analysis and topical takes on the market.
Twitter
Instagram
Show links:
AYR Stock Quote Page
What Cannabis Stocks Should Be In Your Portfolio?
Looking For The Cheapest Cannabis Stocks
Cannabis Is A Long-Term Play
AYR Wellness website
Hirsh Jain joins Jeffrey Schultz to break down what's happening - and what's not - in the New York and California cannabis markets. Updates on New York's legal rollout (5:20), California (13:40), decriminalization without regulation (16:00), pushing for interstate commerce (29:40) and the future of the industry for public companies (50:00).
Our links:
The Cannabis Investing Podcast
The Cannabis Investing Podcast provides actionable investment insight and the context with which to understand the burgeoning cannabis industry.
Seeking Alpha Premium
A comprehensive set of features and analysis that helps take the guesswork out of your investing decisions. Get the bottom-line on any stock or ETF with our Premium tools.
Investing Experts Podcast
Seeking Alpha investing experts provide deep dive stock analysis and topical takes on the market.
Twitter
Instagram
Show links:
Hirsh Jain, Ananda Strategy
Jeffrey Schultz, Feuerstein Kulick
What's The Deal With New York Cannabis?
California's Cannabis Market - A Deep Dive
California Cannabis Market - Deep Dive, Part II
Imran Khan is Executive Director of the Berkeley Center for the Science of Psychedelics.
* With psychedelics, there's more that we don't know than we do (3:00)
* Science behind microdosing - it's too early to tell (5:15)
* Psychedelic placebo challenges (8:00)
* What would the ideal psychedelic space look like? (17:50)
* Retail side of psychedelics (24:45)
* Catalysts and risks (27:30)
Our links:
The Cannabis Investing Podcast
The Cannabis Investing Podcast provides actionable investment insight and the context with which to understand the burgeoning cannabis industry.
Seeking Alpha Premium
A comprehensive set of features and analysis that helps take the guesswork out of your investing decisions. Get the bottom-line on any stock or ETF with our Premium tools.
Investing Experts Podcast
Seeking Alpha investing experts provide deep dive stock analysis and topical takes on the market.
Twitter
Instagram
Show links:
Berkeley Center for the Science of Psychedelics
Imran Khan Twitter
Where Jerry Derevyanny, a partner at Bengal Capital, believes we can find the most value from cannabis stocks. (3:35) Why EBITDA falls short as a useful metric for cannabis investors. (8:15) Moving away from the top multi-state operators (MSOs). (16:20) REITs, problematic business models and risks around rent payment. (22:40) AYR, Goodness Growth and more (30:00).
Our links:
The Cannabis Investing Podcast
The Cannabis Investing Podcast provides actionable investment insight and the context with which to understand the burgeoning cannabis industry.
Seeking Alpha Premium
A comprehensive set of features and analysis that helps take the guesswork out of your investing decisions. Get the bottom-line on any stock or ETF with our Premium tools.
Twitter
Instagram
Show links:
Bengal Capital
Jerry Derevyanny
Bengal Capital 2022 Year End Letter
Jerry Derevyanny Twitter
Dr. Julie Holland is a psychiatrist/psychopharmacologist, author, medical advisor to MAPS, and a medical monitor for several clinical studies.
* (3:30) - Why cannabis is a psychedelic
* (6:00) - Involvement with MAPS; drugs and medicine
* (11:00) - The biggest risk in psychedelic treatment
* (14:30) - Placebos and psychedelics
* (23:00) - Investing in the space, advising psychedelic VC fund
* (29:00) - Psychedelics even more bi-partisan than cannabis, huge for veteran communities and health care professionals
* (35:00) - Humans' relationship with psychedelics
Our links:
The Cannabis Investing Podcast
The Cannabis Investing Podcast provides actionable investment insight and the context with which to understand the burgeoning cannabis industry.
Seeking Alpha Premium
A comprehensive set of features and analysis that helps take the guesswork out of your investing decisions. Get the bottom-line on any stock or ETF with our Premium tools.
Twitter
Instagram
Show links:
Dr. Julie Holland
MAPS
Psychedelic Sunday: Competitive Strategies
Psychedelic Sunday: Scrutinizing Psychedelic Stocks
Ascend (AAWH) has been one of the MSOs that analysts have been writing about on Seeking Alpha and championing on this podcast recently. CFO and interim co-CEO Dan Neville joins us to discuss looking for new leadership and what investors should be focused on in the space.
* (3:10) - The search for Ascend's new CEO
* (11:35) - MSO 2.0 strategy
* (16:40) - Ascend's East Coast assets
* (22:00) - U.S. adult-use ballot initiatives and how Missouri is affecting Illinois business
* (26:30) - Will Ascend be acquired?
* (33:20) - Ascend's Q4 earnings and its cash to debt profile
Our links:
The Cannabis Investing Podcast
The Cannabis Investing Podcast provides actionable investment insight and the context with which to understand the burgeoning cannabis industry.
Seeking Alpha Premium
A comprehensive set of features and analysis that helps take the guesswork out of your investing decisions. Get the bottom-line on any stock or ETF with our Premium tools.
Twitter
Instagram
Show links:
Ascend's Seeking Alpha Quote Page
Ascend Wellness website
Rob Sechrist discusses starting Pelorus Equity Group and its Fund, a privately held mortgage real estate investment trust (mREIT) (2:39) Capital crunch in the cannabis industry ('the income is there; where the difficulty is is deriving net profit from that gross revenue') (6:20) Private operators in California seeing success (10:20) Advice to retail investors (12:50) Investing style and strategy while industry matures (17:40) Cannabis investing in a deflationary environment (34:10) What happens when prohibition ends. (42:00) Doing real due diligence (46:50)
Our links:
The Cannabis Investing Podcast
The Cannabis Investing Podcast provides actionable investment insight and the context with which to understand the burgeoning cannabis industry.
Seeking Alpha Premium
A comprehensive set of features and analysis that helps take the guesswork out of your investing decisions. Get the bottom-line on any stock or ETF with our Premium tools.
Twitter
Instagram
Show links:
Pelorus Equity Group
Pelorus Twitter
Rob Sechrist Twitter
Mental health is perhaps the biggest health issue facing society and traditional medicine has been limited in its success treating it. Psychedelic compounds have been healing people for thousands of years but there are challenges around how to properly service the public. Numinus CEO Payton Nyquvest discusses focusing on profitability and the need for service providers to be able to offer various psychedelic therapies. Possible FDA approval of MDMA this year would be a huge catalyst.
Our links:
The Cannabis Investing Podcast
The Cannabis Investing Podcast provides actionable investment insight and the context with which to understand the burgeoning cannabis industry.
Seeking Alpha Premium
A comprehensive set of features and analysis that helps take the guesswork out of your investing decisions. Get the bottom-line on any stock or ETF with our Premium tools.
Twitter
Instagram
Show links:
Numinus website
Numinus IG
Numinus Twitter
The first ever cannabis investing podcast roundtable discussion with Bryan Fields + Kellan Finney, Benzinga's Javier Hasse and Patrick Aylward. Investing in the cannabis industry: stocks, ETFs and patience (and be honest about risk!). Mistaken assumptions around illicit to legal markets. Confronting synthetic cannabinoids. Excitement over young markets like Oklahoma while bigger markets like New York get figured out.
Our links:
The Cannabis Investing Podcast: https://seekingalpha.com/cannabisinvestingpodcast
On The Cannabis Investing Podcast, host Rena Sherbill provides actionable investment insight and the context with which to understand the burgeoning cannabis industry.
Seeking Alpha Premium: https://seekingalpha.com/premium/getting-started
A comprehensive set of features and analysis that helps take the guesswork out of your investing decisions. Get the bottom-line on any stock or ETF with our Premium tools.
Alpha Picks: https://seekingalpha.com/alpha-picks/subscribe
Alpha Picks gives you two top stock picks each month, sifted from Seeking Alpha’s analysis of thousands of stocks. We do the work. You reap the rewards.
Twitter: https://twitter.com/canpod1
IG: https://www.instagram.com/cannabisinvestingpodcast/
Show links:
Bryan Fields + Kellan Finney - The Dime
Javier Hasse - Benzinga Cannabis Insider
Patrick Aylward - The Cannabis Supply Chain Podcast
Organigram (OGI) CEO Beena Goldenberg talks the changing (and challenging) Canadian cannabis market. Balance sheet strength and British American Tobacco's significant investment. Looking towards the US and beyond. The importance of regulators helping educate consumers.
Our links:
The Cannabis Investing Podcast: https://seekingalpha.com/cannabisinvestingpodcast
On The Cannabis Investing Podcast, host Rena Sherbill provides actionable investment insight and the context with which to understand the burgeoning cannabis industry.
Seeking Alpha Premium: https://seekingalpha.com/premium/getting-started
A comprehensive set of features and analysis that helps take the guesswork out of your investing decisions. Get the bottom-line on any stock or ETF with our Premium tools.
Alpha Picks: https://seekingalpha.com/alpha-picks/subscribe
Alpha Picks gives you two top stock picks each month, sifted from Seeking Alpha’s analysis of thousands of stocks. We do the work. You reap the rewards.
Twitter: https://twitter.com/canpod1
IG: https://www.instagram.com/cannabisinvestingpodcast/
Show links:
Organigram Stock Page: https://seekingalpha.com/symbol/OGI
Organigram website: https://www.organigram.ca/
Organigram Twitter: https://twitter.com/Organigram_Inc
Organigram IG: https://www.instagram.com/organigrams/
Cannabis stocks are really cheap, but Alan Brochstein is worried about 3 things. We discuss sector debt and optimal cannabis investing metrics; Canadian and US operators; concerns around MSOS, limitations of ETFs. Thoughts on the Cresco/Columbia Care deal. Why Alan's 19% in cash.
Our links:
The Cannabis Investing Podcast: https://seekingalpha.com/cannabisinvestingpodcast
On The Cannabis Investing Podcast, host Rena Sherbill provides actionable investment insight and the context with which to understand the burgeoning cannabis industry.
Seeking Alpha Premium: https://seekingalpha.com/premium/getting-started
A comprehensive set of features and analysis that helps take the guesswork out of your investing decisions. Get the bottom-line on any stock or ETF with our Premium tools.
Alpha Picks: https://seekingalpha.com/alpha-picks/subscribe
Alpha Picks gives you two top stock picks each month, sifted from Seeking Alpha’s analysis of thousands of stocks. We do the work. You reap the rewards.
Twitter: https://twitter.com/canpod1
IG: https://www.instagram.com/cannabisinvestingpodcast/
Show links:
Alan Brochstein: https://seekingalpha.com/author/ALAN-BROCHSTEIN-CFA
Village Farms article: https://seekingalpha.com/article/4573501-village-farms-is-deep-value
Canopy Growth article: https://seekingalpha.com/article/4571716-canopy-growth-is-not-a-good-stock-for-cannabis-investors
MSOS article: https://seekingalpha.com/article/4577734-msos-etf-meltdown-hurting-cannabis-stocks
Columbia Care article: https://seekingalpha.com/article/4575545-cannabis-company-columbia-care-is-a-bargain
Red Light Holland CEO Todd Shapiro talks recreational approach to psilocybin and its focus on near-term revenue - a rarity in the psychedelic space. Growing different kinds of mushrooms. Loyal retail investors essential to growth. Recent auditor change. Partnering with Wiz Khalifa, Russell Peters as CCO; path to legalization and profitability. Look at psychedelic companies' run rates.
Our links:
The Cannabis Investing Podcast: https://seekingalpha.com/cannabisinvestingpodcast
On The Cannabis Investing Podcast, host Rena Sherbill provides actionable investment insight and the context with which to understand the burgeoning cannabis industry.
Seeking Alpha Premium: https://seekingalpha.com/premium/getting-started
A comprehensive set of features and analysis that helps take the guesswork out of your investing decisions. Get the bottom-line on any stock or ETF with our Premium tools.
Alpha Picks: https://seekingalpha.com/alpha-picks/subscribe
Alpha Picks gives you two top stock picks each month, sifted from Seeking Alpha’s analysis of thousands of stocks. We do the work. You reap the rewards.
Twitter: https://twitter.com/canpod1
IG: https://www.instagram.com/cannabisinvestingpodcast/
Show links:
Red Light Holland: https://redlight.co/
Red Light Holland on Twitter: https://twitter.com/RedLightHolland
Red Light Holland on IG: https://www.instagram.com/redlightholland/
Wana Brands CEO Nancy Whiteman on being one of the top edible brands in North America and how they grew without outside capital - never take money you don't need. Getting acquired by Canopy Growth, differences between the Canadian and US cannabis markets. Delta 8 and concerns around synthetically derived hemp.
Our links:
The Cannabis Investing Podcast: https://seekingalpha.com/cannabisinvestingpodcast
On The Cannabis Investing Podcast, host Rena Sherbill provides actionable investment insight and the context with which to understand the burgeoning cannabis industry.
Seeking Alpha Premium: https://seekingalpha.com/premium/getting-started
A comprehensive set of features and analysis that helps take the guesswork out of your investing decisions. Get the bottom-line on any stock or ETF with our Premium tools.
Alpha Picks: https://seekingalpha.com/alpha-picks/subscribe
Alpha Picks gives you two top stock picks each month, sifted from Seeking Alpha’s analysis of thousands of stocks. We do the work. You reap the rewards.
Twitter: https://twitter.com/canpod1
IG: https://www.instagram.com/cannabisinvestingpodcast/
Show links:
Wana Brands: https://www.wanabrands.com/
Wana on Twitter: https://twitter.com/WanaBrands
Wana on IG: https://www.instagram.com/wanabrands/?hl=en
Nick Gastevich, aka CannaVestments, one of our favorite commenters on Seeking Alpha, returns for a super actionable take on cannabis stocks. Focus on companies that control their own destinies as much as possible. Which balance sheets are in trouble and who's generating real cash flow. Diving deep into the top multi-state operators + AYR (AYRWF), MariMed (MRMD), C21 Investments (CXXIF), California operators like Lowell (LOWLF), Statehouse (STHZF) and Glass House (GLASF) and more.
Our links:
The Cannabis Investing Podcast: https://seekingalpha.com/cannabisinvestingpodcast
On The Cannabis Investing Podcast, host Rena Sherbill provides actionable investment insight and the context with which to understand the burgeoning cannabis industry.
Seeking Alpha Premium: https://seekingalpha.com/premium/getting-started
A comprehensive set of features and analysis that helps take the guesswork out of your investing decisions. Get the bottom-line on any stock or ETF with our Premium tools.
Alpha Picks: https://seekingalpha.com/alpha-picks/subscribe
Alpha Picks gives you two top stock picks each month, sifted from Seeking Alpha’s analysis of thousands of stocks. We do the work. You reap the rewards.
Twitter: https://twitter.com/canpod1
IG: https://www.instagram.com/cannabisinvestingpodcast/
Show links:
CannaVestments on Seeking Alpha: https://seekingalpha.com/user/49607348/comments
CannaVestments on Twitter: https://twitter.com/CannaVestments
Previous appearances on this podcast:
https://seekingalpha.com/article/4497256-searching-for-cannabis-catalysts https://seekingalpha.com/article/4356531-cannabis-investors-should-be-looking-for-good-stewards-of-capital-podcast-transcript
When will capital markets catch up to the psychedelic industry? Ronan Levy, CEO and Co-Founder of Field Trip, discusses strategy behind focusing on ketamine assisted therapy and why splitting up Reunion Neuroscience (REUN) (drug development) and Field Trip (FTHWF) (clinical infrastructure) made the most sense ('The FDA likes things in neat tidy boxes'). Adult-use psychedelic market has already begun - differentiation will be an issue. In this time of decimated valuations, what should investors focus on?
Our links:
The Cannabis Investing Podcast: https://seekingalpha.com/cannabisinvestingpodcast
On The Cannabis Investing Podcast, host Rena Sherbill provides actionable investment insight and the context with which to understand the burgeoning cannabis industry.
Seeking Alpha Premium: https://seekingalpha.com/premium/getting-started
A comprehensive set of features and analysis that helps take the guesswork out of your investing decisions. Get the bottom-line on any stock or ETF with our Premium tools.
Alpha Picks: https://seekingalpha.com/alpha-picks/subscribe
Alpha Picks gives you two top stock picks each month, sifted from Seeking Alpha’s analysis of thousands of stocks. We do the work. You reap the rewards.
Twitter: https://twitter.com/canpod1
IG: https://www.instagram.com/cannabisinvestingpodcast/
Show links:
Field Trip Health: https://www.fieldtriphealth.com/
Field Trip Twitter: https://twitter.com/fieldtriphealth
Field Trip IG: https://www.instagram.com/fieldtriphealth/?hl=en
Ronan Levy Twitter: https://twitter.com/RonanDLevy
Ronan Levy IG: https://www.instagram.com/ronandlevy/
Ronan's 1st appearance: https://www.spreaker.com/user/16831773/shifting-focus-from-cannabis-to-other-ca
How should cannabis investors ride the wave of depressed valuations? Tiby Erdely, who came to cannabis from Goldman Sachs and co-founded KEY Investment Partners, talks about why consolidation is coming. We also discuss why investors should get deep into companies' income statements and balance sheets and focus primarily on the last 6-12 months of performance. Why the top 5 multi-state operators (Trulieve (TCNNF), Green Thumb Industries (GTBIF), Curaleaf (CURLF), Cresco (CRLBF), and Verano (VRNOF)) are separating from the pack. Canopy Growth (CGC) and Tilray (TLRY): Canadian operators' U.S. intentions - keep a close eye on Nasdaq setting a precedent.
Our links:
The Cannabis Investing Podcast: https://seekingalpha.com/cannabisinvestingpodcast
On The Cannabis Investing Podcast, host Rena Sherbill provides actionable investment insight and the context with which to understand the burgeoning cannabis industry.
Seeking Alpha Premium: https://seekingalpha.com/premium/getting-started
A comprehensive set of features and analysis that helps take the guesswork out of your investing decisions. Get the bottom-line on any stock or ETF with our Premium tools.
Alpha Picks: https://seekingalpha.com/alpha-picks/subscribe
Alpha Picks gives you two top stock picks each month, sifted from Seeking Alpha’s analysis of thousands of stocks. We do the work. You reap the rewards.
Twitter: https://twitter.com/canpod1
IG: https://www.instagram.com/cannabisinvestingpodcast/
Show links:
KEY Investment Partners: https://keyinvestmentpartners.com/
As the industry develops, lots of talk recently around cannabis consumption lounges and cannabis tourism in Colorado, Nevada and beyond. What it's like to grow the cannabis economy with Chris Chiari, CEO/Founder of The 420 Hotels. Cannabis is a commodity - what that means for pricing and business models.
Our links:
The Cannabis Investing Podcast: https://seekingalpha.com/cannabisinvestingpodcast
On The Cannabis Investing Podcast, host Rena Sherbill provides actionable investment insight and the context with which to understand the burgeoning cannabis industry.
Seeking Alpha Premium: https://seekingalpha.com/premium/getting-started
A comprehensive set of features and analysis that helps take the guesswork out of your investing decisions. Get the bottom-line on any stock or ETF with our Premium tools.
Alpha Picks: https://seekingalpha.com/alpha-picks/subscribe
Alpha Picks gives you two top stock picks each month, sifted from Seeking Alpha’s analysis of thousands of stocks. We do the work. You reap the rewards.
Twitter: https://twitter.com/canpod1
IG: https://www.instagram.com/cannabisinvestingpodcast/
Show links:
The 420 Hotels: https://the420hotels.com/home
Stephen Tobin on investing in psychedelic stocks while they're still pre-revenue. Why he's a big believer in Compass Pathways (CMPS) and Atai Life Sciences (ATAI) and not as much in Cybin (CYBN) or MindMed (MNMD). Will first-movers get the advantage? What will move share prices? The importance of patents and cash in the industry.
Legal cannabis has officially hit New York. Two long-time advocates, Allan Gandelman and Kaelan Castetter, came on when New York first went legal and return to provide context for this moment. We discuss when supply might meet demand, why the two-tier system works and will likely be a federal model, the illicit market, and the obscene value of NY licenses.
What makes a psychedelic company compelling? Analyst Alex Carchidi has a background in biotech and focuses on long-term growth and risk management. He shares what investors should focus on in the psychedelic space and the pros and cons of owning his top 5 psychedelic stocks.
Negative conditions are crashing down all around investors. Make sure companies in your portfolio will survive. Ted Waller shares why some stocks are falling off a cliff. Not all ETFs are created equal - stay away from the leveraged ETFs ('dynamite ready to be lit'). Pinning hopes on current cannabis leaders. Cash flow is extremely important.
James Baker and Julian Lin are two standout analysts who have joined us over the years for 3 MasterClasses in cannabis investing. This is a compilation of highlights from those shows. As the last episode of the year, and as we've been met with more political gridlock and disappointment, we would do well to remind ourselves of some investing truths, let go of outdated hopes and focus more on descheduling than banking reform. On the crash that came, uplisting, internal and external growth, goodwill and intangible assets and why cash flow is more important than adjusted EBITDA.
Welcome to the 2nd episode of Psychedelic Sunday, where we delve into psychedelics and investing. Today we give an overview of the 4 main stocks in psychedelics, focusing on recent earnings calls and analyst Q&A for Compass Pathways (CMPS), Atai Life Sciences (ATAI), MindMed (MNMD) and Cybin (CYBN). We'll be diving even deeper into these stocks over the next couple of weeks with the help of Stephen Tobin and Alexander Carchidi.
Celebrating episode 200 with Emily Paxhia! Time to reset expectations and focus the conversation on rescheduling (or descheduling!) cannabis. Dysfunction at the federal level - not passing cannabis banking reform is in direct opposition to majority of US voters. Sidestepping the froth with the PSDN ETF. Small cap value story. Top companies already positioned for uplisting, but what are the rules of the game? Resigning from Ascend Wellness Board, addressing the rumors. Advice and support for retail investors.
Welcome to the first ever Psychedelic Sunday episode! There is a lot of overlap between cannabinoid and psychedelic experiences and today we launch our coverage of the psychedelics industry. Challenges and opportunities within psychedelics; highlighting four stocks: Compass Pathways (NASDAQ:CMPS), Cybin (NYSE:CYBN), Atai Life Sciences (NASDAQ:ATAI), and MindMed (NASDAQ:MNMD).
How should you build your cannabis portfolio? Analyst Jesse Redmond shares his thoughts on MSOs, ETFs and smaller players. Green Thumb resignations, stepping away from Ascend. California, New Jersey and the obligatory SAFE discussion. His favorite strains and why he grows his own cannabis.
With tech stocks crashing, are cannabis stocks the most compelling investment right now? Julian Lin tells investors to focus on MSOs that can generate free cash flow right now. Price compression has been far more severe than expected. What rising interest rates means for the cannabis industry. Why Julian's so bullish on NewLake Capital.
Fairly disappointing news out of the US as only 2 of the 5 states that had adult-use cannabis on the ballots passed it. With Biden's recent promises amid a protracted regulatory process, will investors' and activists' frustration lead to change? What we as investors can look forward to in the industry.
Glass House aims to be free cash flow positive. Co-Founder and President Graham Farrar comes back to discuss the opportunity and challenge in fighting its main competition - California's illicit market. We also discuss why he thinks Biden's recent announcements are more strategy than stunt and why Glass House won't be at MJBizCon.
BDSA provides market research and data solutions for the cannabis industry. CEO Roy Bingham discusses state by state legalization, development of illicit market, lack of consequences. Why he's cautious about the international market.
Agrify (AGFY) CEO Raymond Chang joined me last year on CEO Interviews to discuss the business model of indoor vertical farming. We recorded this interview before Agrify's recent stock split, but we do discuss the current challenging environment and the pivot the company is now focused on. Rapid deployment, the necessity for consistency, addressing industry pain points and growing segments.
Entourage Effect Capital Founder and StateHouse (STHZF) Chairman Matt Hawkins returns to discuss cautiously hunting for distressed assets, the transformative outlook of new regions going legal and developing legislation. Private equity, institutional capital wanting in on cannabis.
Weedmaps CEO Chris Beals joined me recently at Benzinga's Cannabis Capital Conference to discuss scaling a cannabis marketplace. The arduous task of policing the platform, whether brand loyalty really exists and the catalyst that people aren't talking about.
Chief Investment Officer Aaron Miles shares why Verano (VRNOF) got dinged when it went public and how it's shaping its strategy as the market continues to develop. We discuss the Goodness Growth (GDNSF) acquisition, New York's protracted timeline and investing dollars at the right time. One of the top MSOs, find out why Seeking Alpha authors and Wall Street analysts rate Verano as a Strong Buy and why momentum is a concern.
Live from Chicago's Benzinga Cannabis Capital Conference with Fast Money's Tim Seymour! Why MSOs are still the most interesting investments but some are separating from others. Tim's conversation with Boris Jordan. Oversupply in the market. People aren't as optimistic and why that's a good thing.
Cannabis flower usage and pre-rolls with Lowell Farms' Chairman George Allen. The developing retail picture, competitive form factors and the maturing consumer. Lowell's new 35s, bringing elegance to joints and making sense of the industry.
Talking cannabis legalization in Germany with Niklas Kouparanis, CEO and Co-Founder of Bloomwell Group - one of Germany’s largest cannabis companies. We talk about legalizing the whole value chain. The mistake of decriminalizing before legalizing. Learning the lessons from already legal markets.
Coming from blue chip CPG companies like Clorox, Troy Datcher came on board as CEO for TPCO Holding (GRAMF) last year. Troy said that he's longed to have a relationship this intimate with the consumer in previous industries. "Candidly, I didn't own the experience." In cannabis TPCO reaches about 70% of California consumers. Creating a different company from how it started. Encouraged by legislative changes in California, but it's not enough. For those that can, influence the outcome.
Spending more time on the California cannabis market with Lauren Fontein, one of the founders of The Artist Tree, a beautiful new consumption lounge in West Hollywood and Courtney Caron, an instrumental part of the developing retail picture in California. This week we sat on the lounge's balcony and discussed the baby steps happening in the cannabis industry, what retail consumption looks like, and what's holding the state - and country - back from real growth.
Emily Paxhia and Hirsh Jain return to catch us up on the California cannabis market and beyond. Getting out of the death spiral but not quite out of the woods yet. Elimination of cultivation tax, but other taxes remain. Incremental progress, but is California moving in the right direction? What parts of the supply chain will benefit? Cannabis pricing, legal vs illicit. Moving towards commoditization.
Jon DeCourcey shares how his cannabis investing philosophy has shifted over the past few months. Micro vs macro perspective, risk on vs risk off environment. What is going on in Washington? Is there reason for more optimism on political front? Moving pieces of continued cannabis expansion and what's happening beyond companies' control. Learn more about your ad choices. Visit megaphone.fm/adchoices
Happy to have Alan Brochstein back! Thoughts on the recent rally (less about Bulls buying than Bears covering), political doubts and overall optimism. Valuations are low, but there's good news across the States. These stocks are really cheap. Mistake to assume margins will go down. Analyzing Canopy Growth (CGC), Curaleaf (CURLF), AYR Wellness (AYRWF), Ascend (AAWH) and more. Learn more about your ad choices. Visit megaphone.fm/adchoices
Alan Sumler comes from the world of academia. We discuss his long positions in cannabis and how he approaches his stock analysis. How history influences his cannabis investing and looking at short-term movements through a long-term lens. A rare opinion - Positive on Canada! Playing options, balancing technical and fundamental analysis and problems with the way we cover cannabis investing. Learn more about your ad choices. Visit megaphone.fm/adchoices
Brad Thomas, who runs iREIT on Alpha, breaks down why cannabis REITs are an income play and a growth story. Lack of federal legalization affords cannabis REITs a strong opportunity as real estate is a big part of the industry. We discuss the value of licenses, leases, good and bad tenants. Brad's bullishness on Innovative Industrial Properties (IIPR), as well as NewLake Capital (NLCP), AFC Gamma (AFCG) and Power REIT (PW). Learn more about your ad choices. Visit megaphone.fm/adchoices
Catching up on the cannabis industry, we revisit some of our most salient analysis of the past 6 months. Jon DeCourcey covers upcoming tailwinds; Jason Powers and Julian Lin talk valuations and compare undervalued tech to cannabis and Nick Gastevich discusses returning to former growth rates as more states come online. Learn more about your ad choices. Visit megaphone.fm/adchoices
Ted Waller joins us again to discuss staying bullish but getting more realistic about the cannabis industry. Limited growth rates, margin compression and the need to keep our emotions out of investing. Buying special situations and what stocks are more concerning. Learn more about your ad choices. Visit megaphone.fm/adchoices
Julian Lin, founder of Cannabis Growth Investor, returns to discuss two of his favorite cannabis plays - a REIT and an MSO. Cannabis investing philosophy (valuations should drive capital allocations). Net leases, cap rates and how legislation may affect bullish thesis. Smart acquisitions, management compensation, inside ownership and understanding high debt. Learn more about your ad choices. Visit megaphone.fm/adchoices
With Ascend Wellness - and perhaps other MSOs - set to sue the US government, we think it's a good time to hear directly from cannabis executives to get their thoughts on the industry. We hear from TerrAscend 's Jason Wild, Ascend Wellness' Abner Kurtin, MariMed's Bob Fireman and Weedmaps' Chris Beals. As we hit mid-year, we hope this brings you more clarity into understanding the sector! Learn more about your ad choices. Visit megaphone.fm/adchoices
Capital is disappearing in the cannabis industry. Mike Regan and Colin Ferrian return and we discuss what investors need to understand about valuations (it's not just like tech). Grading California's main players, consumption patterns, price erosion. EBIDA over EBITDA. For a real transparent take on California trends, listen to Scotts Miracle-Gro conference call every quarter. Cyclical trends amidst secular growth and Colin turns the tables on me! Learn more about your ad choices. Visit megaphone.fm/adchoices
Dr. Robin Goldstein and Professor Daniel Sumner wrote Can Legal Weed Win?: The Blunt Realities of Cannabis Economics, an objective take on understanding the long-term economics of legal and illicit cannabis. Competition between legal and illicit market - not clear who wins. What types of policies will help legal weed win, learning from other commodity markets and why having a cash cushion is essential. The benefits of being a craft brand and why regional identity is key. Learn more about your ad choices. Visit megaphone.fm/adchoices
Patience, more institutional capital and more catalysts, but mostly we need patience as we wait for the industry to grow into a more mature sector. Matt Hawkins returns to discuss StateHouse/Harborside, the California cannabis market and the developing US landscape. Advice to retail investors and why managing cash is key. Institutional capital will come in and everyone will want in on an MSO or wanting to partner with an MSO. That's where the money is going to be made. Learn more about your ad choices. Visit megaphone.fm/adchoices
Michael Auerbach, Founder and Chairman of Subversive Capital and The Parent Company (OTCQX:GRAMF) first came on for our first two SPAC Weeks and returns today to update us on GRAMF and the growth that hasn't shown up the way we expected. InterCure and the Israeli market. We also discuss his new ETF PUNK, which came on the scene and shorted Meta. Learn more about your ad choices. Visit megaphone.fm/adchoices
Julian Lin catches us up on recent earnings volatility, valuations and how investors should be looking at the cannabis industry. Why he's a big fan of Verano but not a fan of the Cresco/Columbia Care merger. IIPR, NewLake Capital and why cannabis REITs are highly compelling. Learn more about your ad choices. Visit megaphone.fm/adchoices
4/20 is a time to celebrate the plant and industry but also a time to reflect on how much further we still need to go. Growing up in a farming family, Reginald Stanfield started JustinCredible Cultivation, the first non-equity, Black-Owned Cannabis Cultivation in Massachusetts. We discuss the two different cannabis industries; working with Curaleaf, navigating the challenges of raising capital, evolving regulations and reasons for optimism. Learn more about your ad choices. Visit megaphone.fm/adchoices
Jon DeCourcey from Viridian Capital Advisors returns to discuss recent earnings and why disappointment is overblown. Favoring quality, underappreciated names in the cannabis industry due to favorable fundamentals and growth opportunities. These names also benefit from consolidation in the space at a time where it's hard to find alpha in the sector. Learn more about your ad choices. Visit megaphone.fm/adchoices
Guy Rocourt is President, CEO and co-founder of Papa & Barkley, a pillar of California cannabis brands set to roll out nationally this year and recently joined Christian Cannabis. Pushing back on problematic corporate cannabis. Building a brand with solventless sustainable products. Why many MSOs aren't in California - a branding knife fight. Normalizing cannabis - if you use cannabis, say something. Learn more about your ad choices. Visit megaphone.fm/adchoices
Nick Gastevich, one of our favorite commenters on Seeking Alpha, returns to the show to catch us up on the state of cannabis investing. Recent earnings, effects from macro pressures, and how Nick looks at recent consolidations. Illinois' social equity program had the right idea but large MSOs have had too much of a head start. Wave of new states legalizing cannabis now especially important in the face of long federal delays. Learn more about your ad choices. Visit megaphone.fm/adchoices
Tim Seymour returns to talk cannabis investing within current market conditions. Interconnectivity between asset classes in the time of war and geopolitical volatility. Legislative process, wholesale prices, compression and recent cannabis earnings. Cannabis IPOs, ETFs and looking for free cash flow generation. Learn more about your ad choices. Visit megaphone.fm/adchoices
Alisia Ratliff is CEO of Victus Capital Ventures and returns again on International Women's Day to discuss the European cannabis markets, what has Alisia excited about the scientific and business breakthroughs in the industry and pursuing a more equitable path in the industry. Learn more about your ad choices. Visit megaphone.fm/adchoices
Jay Czarkowski, an experienced cannabis expert, returns to discuss why he's betting big on the Northeast. East Coast over California - fresh legal industry to develop. Importance of controlling real estate and gaining local support. Rethinking our timeline around interstate commerce. Favorite mid-tier stocks. Learn more about your ad choices. Visit megaphone.fm/adchoices
Federal cannabis legalization is not the end all, be all - investors would be wise to think it will take longer than expected. How should we think about a growing green map in the US when the market's not responding to it? Cannabis' growth story and what that means for valuations. Julian Lin and Jason Powers' compelling and essential conversation for cannabis investors. Learn more about your ad choices. Visit megaphone.fm/adchoices
Deep dive on the California cannabis market with industry experts Emily Paxhia and Hirsh Jain. Pain points and reasons for cautious optimism. Taking stock of the California players. The stocks not getting enough attention in the state (it may surprise you!) and why investors should be wary of companies not reporting GAAP figures. Learn more about your ad choices. Visit megaphone.fm/adchoices
Trulieve CEO Kim Rivers is one of the top cannabis operators. Trailblazing the path of going deep not wide. Moving beyond Florida. Harvest acquisition. Gross margins and profitability. Learn more about your ad choices. Visit megaphone.fm/adchoices
Cannabis industry expert Alan Brochstein on the current state of cannabis and 2022 catalysts. New York and New Jersey's path to legalization, how to look at consolidation. Direct listings and SPACs, cannabis REITs, Curaleaf and Verano. MedMen/Ascend Wellness deal breakdown unsurprising. Learn more about your ad choices. Visit megaphone.fm/adchoices
Julian Lin, who runs Cannabis Growth Investor on Seeking Alpha, reminds cannabis investors to focus on the fundamentals. Why the Florida market is underrated and why some are thinking about the downturn all wrong. 2022 conjectures, why SAFE Banking won't pass and long-term bullishness. Learn more about your ad choices. Visit megaphone.fm/adchoices
Jon DeCourcey, formerly of Canaccord now with Viridian Capital Advisors, also publishes his analysis on Seeking Alpha. We discuss recent cannabis earnings and why he favors mid-tier multi-state operators (MSOs) over the Big 5. SAFE Banking expectations, how he sees valuations growing. Why retail investors should be excited for stalled cannabis legislation. Uplisting catalyst is misunderstood. Why Ayr Wellness is one of our top picks and some seriously actionable investment advice. Learn more about your ad choices. Visit megaphone.fm/adchoices
Kristen Yoder, host of The CannaBS Detector and a cannabis veteran, gives an unvarnished take on the cannabis industry. Kristen's #1 complaint about the industry. Why she'd rather be short cannabis stocks than long and where she does feel comfortable putting her money. Learn more about your ad choices. Visit megaphone.fm/adchoices
Fantastically timely and edifying episode with industry expert Brady Cobb. We talk recent legislation; moving from optics to real reform. SAFE Banking, uplisting and what legislation will mean for cannabis investors. MSOs, ETFs new and old, future valuations, Florida and NY/NJ markets; selling to Cresco, focus on premium products. Learn more about your ad choices. Visit megaphone.fm/adchoices
I talked to Oren Shuster, CEO of IM Cannabis, this week in Tel Aviv at its CannaBIZ conference. We discuss the significant share price decline in the industry across the board; the significance of the Republican announcement in the US. Israel's unique market, comparisons to Michigan; Germany and Europe and the growth still to come. Learn more about your ad choices. Visit megaphone.fm/adchoices
Green Flower, founded by CEO Max Simon in 2014, is a training platform built for cannabis professionals. Ganjier is its cannabis sommelier certification program. The GF Institute is its newest effort, focused on cannabis workforce development - 30 leading companies including AYR Wellness and Cresco, are founding member brands. Developing standardized process to asses cannabis quality. The people problem in the industry. Learn more about your ad choices. Visit megaphone.fm/adchoices
As the industry develops, interesting to see how and where. Digital content + cannabis = The Cannigma. Co-Founder and COO Wassim Bahous and CEO Elana Goldberg joined the podcast to talk starting a cannabis publication during the pandemic, the mission to make science-backed information more accessible. Majority of content mostly useful to those living in legal markets; global approach, different languages. Learn more about your ad choices. Visit megaphone.fm/adchoices
"You should never feel bad about feeling good." Jim Belushi, actor and founder of Belushi Farms, sums up his feelings about cannabis. He joins Jeremy Corrao, Vice President of Commercial Operations at GrowGeneration to discuss their recent partnership, plans for greenhouses and how to get yields up. Advocating for change, home grow market and GRWG's plans for growth. Getting the band back together at MJ Unpacked! Learn more about your ad choices. Visit megaphone.fm/adchoices
Lincoln Johnson, Co-Founder, CEO + CTO of EnCann, returns to the podcast to catch us up on the extraction space ("we're going to see a big shift") and his journey since we talked previously back in 2019. A fantastic take on starting up a cannabis business, navigating the industry, and what Lincoln learned from a long (and ultimately successful) arbitration process. Learn more about your ad choices. Visit megaphone.fm/adchoices
InterCure is the most profitable cannabis company outside North America and recently uplisted to the Nasdaq. Israel's former Prime Minister, Chairman Ehud Barak and CEO Alex Rabinovitch join Rena Sherbill to discuss Israel's cannabis landscape and what investors can expect going forward. Europe's gradual progress, building a strong brand with top international names. Upside remains. Learn more about your ad choices. Visit megaphone.fm/adchoices
180 Life Sciences' Prof. Sir Marc Feldmann, who co-founded the company with cannabis trailblazer Prof. Raphael Mechoulam, joins Rena with Dr. Jonathan Rothbard, Chief Science Officer. Focusing on pain and inflammation space. Aiming for FDA approval. Human clinical trials. Limitations of bioavailability in CBD; non-psychoactive synthetic CBD. Learn more about your ad choices. Visit megaphone.fm/adchoices
Tim Seymour returns to discuss cannabis investors getting more sophisticated as the industry grows up. Holding management teams more accountable, multiple quarters of execution, profitability as a relative term. Macro picture is both tremendously promising and frustrating. The importance of access to capital. Deep thoughts on the US landscape; Tilray/MedMen, Trulieve, Gage and more consolidation. Learn more about your ad choices. Visit megaphone.fm/adchoices
Elad Barak founded Voyager Products, a health tech startup creating personalized dosing dispensers for cannabis beverages. Focused on hardware side, proprietary technology. Concentrates; ready-to-drink and make-your-own-drink projections. Applications beyond cannabis; hardware patents. Learn more about your ad choices. Visit megaphone.fm/adchoices
Brian Sekandi started careerscannabis.com, the first job search engine for the cannabis industry in North America. Simplifying the application process and improving the recruitment experience with digital technology. He also wrote a book, Kids In Cannabis, to further understanding and lessen the stigma around working in the industry. Incremental change in improving industry standards around hiring. Learn more about your ad choices. Visit megaphone.fm/adchoices
Julian Lin, from our MasterClass episodes, has a new cannabis focused marketplace service, Cannabis Growth Portfolio. We discuss his thoughts on EBITDA, ETFs using total return swaps to own US MSOs, rebalancing away from Canadian operators. Uplisting is the clearest catalyst for cannabis stocks. Tilray coming for the US. Legalization is not the thesis to owning cannabis stocks. California concerns. Learn more about your ad choices. Visit megaphone.fm/adchoices
Alan Brochstein, a friend of the podcast and now a 3peat guest, is the founder of 420 Investor and New Cannabis Ventures. We talk uplisting - which doesn't require full legalization - and why the longer legalization takes the better for cannabis companies. The need for education and separating Canadian players from those in the US. Alan's thoughts on [[MSOS]], volume and valuation issues and confronting the California cannabis landscape, including The Parent Company and Glass House. Why there's no winner take all in U.S. cannabis until federal legalization. (We apologize for a less than stellar audio experience but do have a transcript available: https://seekingalpha.com/article/4450076-alan-brochstein-the-longer-legislation-takes-the-better-for-cannabis-companies-podcast-transcript) Learn more about your ad choices. Visit megaphone.fm/adchoices
George Jage, former president of MJBizDaily/MJBizCon and CEO of Dope Media, shares how he learned how to build out a nascent industry from the tea industry and bringing that into cannabis with trade shows and business media platforms. Founding Jage Media with a veteran team of cannabis investors right before Covid hit. MJ Unpacked, coming this October to Las Vegas, their upcoming trade show that brings cannabis retail executives, investors and brands all together. We talk about focusing on what a CPG market needs and unpacking the future of legalization, what it means for investors and consumers. Unlocking valuation. Learn more about your ad choices. Visit megaphone.fm/adchoices
Cannabis company TerraTech recently finalized its merger with Unrivaled and the two California-based companies with combined operations in California, Oregon and Nevada (which represents about 30% of the entire US market) is now known as Unrivaled Brands (OTCQX:UNRV). CEO Frank Knuettel joined Rena to discuss the merger, West Coast landscape, and the developing cannabis future politically and legally. Bringing on further complementary assets and correcting previous management's missteps. Recent Board additions bring cannabis industry knowledge and operational savvy. Learn more about your ad choices. Visit megaphone.fm/adchoices
Gage is a cannabis operator solely focused on the Michigan market, which is the third largest state in terms of cannabis consumption. CEO Fabian Monaco joins the show to discuss learning from those that came before him, getting investment insight from Bruce Linton, Jason Wild and Tim Seymour and following Trulieve's example. Gage's exclusive partnership with Cookies, plans for expansion and thoughts on developing legal picture. Learn more about your ad choices. Visit megaphone.fm/adchoices
Jason Wild, who started out as a pharmacist, is President of JW Asset Management and Executive Chairman of US multi-state operator TerrAscend (TRSSF). He joins us to discuss starting his successful investing journey by reading Peter Lynch and by being disciplined about holding his winners and selling his losers relatively quickly. Following Trulieve's example of going deep but not wide. More focused, more scale in less places means better margins over near and long-term. Don't be too focused on federal legalization - you can't make money betting on what's going to happen in Washington. Learn more about your ad choices. Visit megaphone.fm/adchoices
Adrian Sedlin is founder and CEO of Canndescent, a vertically integrated flower brand out of Santa Barbara, CA that offers a number of brands including Justice Joints, which donates 100% of all profits to social equity efforts. California's cannabis landscape suffers from oversupply and not enough legal retail, an unregulated grey market that's 2-3x the size of legal market. Incumbents know their way around; some will be bought by those with large balance sheets, some will head East. Learn more about your ad choices. Visit megaphone.fm/adchoices
Sturges Karban, CEO of ManifestSeven, on building the Amazon of the cannabis space. Focusing on California and dealing with its dichotomous nature. Expanding legalization and how it affects the industry. Salience of establishing your time horizon. Learn more about your ad choices. Visit megaphone.fm/adchoices
Emily Paxhia is co-founder and Managing Partner of Poseidon Asset Management, one of the earliest and longest-running funds in the cannabis space. Today we discuss the disappointing political picture around cannabis decriminalization and legalization, the path forward for bigger and smaller players in the industry, what Amazon's support of cannabis signals, MSOs diversifying strategies and what cannabis investors should be paying attention to as we come to terms with remaining stigmas and being a capital-deprived industry. Learn more about your ad choices. Visit megaphone.fm/adchoices
Seeking Alpha authors James V. Baker and Julian Lin return for our Master Class 3 after bringing so many cannabis investors so much insight and profit in episodes one and two. We catch up about their investing styles, where they think we are in the valuation cycle, what the developing legalization picture means for multi-state operators and investors and what stocks look strong. Learn more about your ad choices. Visit megaphone.fm/adchoices
'We think a lot about cost of capital. Access to capital at low cost.' - Green Thumb CEO Ben Kovler, who joins Rena to discuss strong gross margin, net income profitability and free cash flow generation despite onerous cannabis tax regulations. Common-sense approach to cannabis winning out. Massive consumer demand. US consumed with cannacuriosity. Being ready for but not dependant on the next phase of legalization. Learn more about your ad choices. Visit megaphone.fm/adchoices
Glass House Group going public via Mercer Park SPAC. President and Co-Founder Graham Farrar joins us to talk consolidating California cannabis. Brand, product focused and control of the shelf space - consistently EBITDA positive, California's mature and immature market. Supply agreement with The Parent Company, plans for expansion; the Casamigos of cannabis. Learn more about your ad choices. Visit megaphone.fm/adchoices
As the cannabis community has grown into an industry it's imperative we don't lose track of who and what got us here so today we launch a new Legacy series of the podcast where I talk to people coming from the legacy side of cannabis, way back before the Green Rush started. In Jimmy's own words: "Sometimes when prayers are answered they don’t get answered exactly as you expected. I think the law in California that legalized cannabis could have been written better but overall is a good thing for society and a step in the right direction. This is what people have been dreaming about and fighting for, for decades. I'm not sure if everyone fighting wanted so many laws that came with legalization but I guess that’s the nature of the beast. One of the things I love most in life is smoking cannabis that I grew. I highly encourage others to do so as it is one of the most satisfying, and rewarding ways to connect with the plant. The connection to the plant and the love for it, is the biggest thing the legacy has to offer. I hope anyone who joins the industry finds that connection."
Learn more about your ad choices. Visit megaphone.fm/adchoices
Are investors ready for the next leg of cannabis legalization and what it does to cannabis companies? That's a question asked by Mike Regan and Colin Ferrian who run MJResearchCo, which provides rigorous investment analysis of the legal cannabis industry. We also discuss the Trulieve/Harvest deal, various players set on dominating California, and what makes a strong operator. Learn more about your ad choices. Visit megaphone.fm/adchoices
Agrify is a developer of grow solutions for indoor agriculture, primarily for the cannabis market. CEO Raymond Chang joins Rena to discuss why indoor vertical farming will change the industry. CPG as the future of cannabis. Driving science, data and consistency. Importance of genetics and grow environment. Proprietary measures around design and safety. Building cannabis insight.
Learn more about your ad choices. Visit megaphone.fm/adchoices
California is perhaps the most attractive cannabis market and certainly the most mature so it's no doubt strong players are interested. Matt Hawkins, founder of Entourage Effect Capital, recently came on as Chairman of Harborside, a legacy California company. Goal of being the best single state operator, moving on from fights with IRS, and confident about banking. Learn more about your ad choices. Visit megaphone.fm/adchoices
Red White and Bloom CEO Brad Rogers talks aggressive strategy after being 5 years late to the cannabis game. Establishing presence in the US with strong brands in compelling states. Canadian players without a US strategy will be left behind. US MSOs building formidable moat. Learn more about your ad choices. Visit megaphone.fm/adchoices
MariMed is a vertically integrated multi state cannabis operator. CEO Bob Fireman joins Rena Sherbill to discuss why he thinks they're undervalued. Giving guidance, changing messaging and cleaning up balance sheet from previous debt. Full legalization and uplisting closer but still far off - that's the game changing moment. Protecting the creators of the industry, not wanting to become one of the bad guys. Learn more about your ad choices. Visit megaphone.fm/adchoices
Vireo Health founder and CEO Dr. Kyle Kingsley returns to the show to talk huge opportunity in US as Arizona, New Mexico and New York legalize adult use cannabis. Legalization doesn't automatically improve your business unless you can scale on operational excellence. Compelling potential in Resurgent Biosciences - Vireo's IP business. Being on the path to profitability. Learn more about your ad choices. Visit megaphone.fm/adchoices
Happy 4/20! To celebrate, we're joined by Kaelan Castetter and Allan Gandelman, who played an integral part in New York legalizing cannabis. The key to true social equity and why limited licenses stifle innovation and create an unequitable marketplace. Very bullish on non-psychoactive cannabinoids. Hemp for industrial use probably has the highest ceiling. Learn more about your ad choices. Visit megaphone.fm/adchoices
The cannabis industry as it stands today is 5% of what it's going to be - so says Jay Czarkowski, Founding Partner at Canna Advisors. Chasing competitive licenses, opportunities in MORE Act, MSOs primed to succeed, as well as some under the radar companies. Companies likely to be acquired, example of why management is the most essential thing when evaluating a company. Learn more about your ad choices. Visit megaphone.fm/adchoices
Kellen O'Keefe, CEO at Flower One joins Rena Sherbill to discuss his journey from MedMen, what he's learned along the way and what he's excited about in Nevada. Building valuable corporate governance. Management changes throughout the cannabis industry, moving from license acquirers and expanders to strategic operators. MSOs building their advantage through evolving legalization. Inter-state commerce still far off. Learn more about your ad choices. Visit megaphone.fm/adchoices
Why aren't US cannabis stocks reflecting more fundamental bullish developments? CNBC's Tim Seymour joins Rena Sherbill to discuss this and his actively managed ETF, CNBS. Top line revenue will be very robust this year. SAFE Banking and waiting to hear what happens in Texas. Cannabis coverage on CNBC, understanding US and Canadian opportunities. It's about finding the companies building the foundation for a consumer products industry as well as the innovations leapfrogging other technologies. Learn more about your ad choices. Visit megaphone.fm/adchoices
Jushi Holdings CEO Jim Cacioppo discusses managing growth and taking a leap in the US cannabis industry. Growing strategically and avoiding pitfalls of cannabis industry; good management is essential. Volatility in the market. Picking the right company in cannabis after many got it wrong, advantages of being an MSO. Learn more about your ad choices. Visit megaphone.fm/adchoices
Chris Driessen, CEO at SLANG Worldwide talks about being focused on the tremendous opportunity in US cannabis. Speaking the language of CPG, reliance on data, consumer analytics. Small nuance in between markets, but largely same series of events. Share price volatility. Growth in enterprise value and clever consolidation. Learn more about your ad choices. Visit megaphone.fm/adchoices
Kimberly Bambach is CFO at Jushi Holdings, a growing US multi state operator with a strong capital market background. Pursuing accretive acquisitions, targeted approaches, raising debt for scale and growth. Overwhelming competence as currency, raising guidance, plans for new and existing markets in the US. Learn more about your ad choices. Visit megaphone.fm/adchoices
Supreme Cannabis is a promising turnaround story out of Canada, thanks in large part to its CEO, Beena Goldenberg. Delivering sustainable profitability, driving revenues and the developing Canadian retail picture. Being a role model for women executives and thoughts on the global cannabis landscape. Learn more about your ad choices. Visit megaphone.fm/adchoices
Celebrating International Women's Day with Alisia Ratliff, Scientist and CEO of Victus Capital Ventures. A frank conversation about the frustrations of being the only woman in the board room; the push to keep evolving and starting Victus with her husband Chris. Leading with science and data. Building awareness and strategic change. Loving extraction and new cannabinoids coming online. The stress of having IPs without capital. Learn more about your ad choices. Visit megaphone.fm/adchoices
Australis Capital CFO Jon Paul joins Rena Sherbill to discuss closing its acquisitions and why coming on board was a bet on CEO Terry Booth. How MSOs will rationalize over time and optimism on banking opening up. IPOs, SPACs and why the FDA needs to provide more certainty on CBD. Learn more about your ad choices. Visit megaphone.fm/adchoices
Indus' George Allen returns to the show to announce its exciting new deal with Lowell Herb. Consolidation is the name of the game in cannabis - this isn't the last deal they'll do but the one they always wanted to do. Playing the value game, Lowell is at the top of sought after brands, doesn't have to fight for shelf space. High quality flower, moving away from concealing cannabis - invites the mainstream in. Learn more about your ad choices. Visit megaphone.fm/adchoices
Logistics are an essential part of cannabis, but it's an area where people aren't looking. Yoram Eshel led supply chain and logistics at Teva and now runs Cannabilog, an Israeli company that closes the gap between growing, manufacturing and supply chain/logistics management. There are new and more elaborate regulations around ever evolving innovations in medical cannabis and there's a big gap in managing this in cannabis industry. Where regular pharma fails, cannabis steps in. Inter-state commerce, importing and exporting over global borders. Cannabis growth comes from the bottom up - unlike most other industries that grow from the top down. Learn more about your ad choices. Visit megaphone.fm/adchoices
Michael Auerbach returns to discuss Subversive's recent deal with leading Israel cannabis company, InterCure and gives an update on The Parent Company. Why Subversive pivoted from a REIT to a SPAC, Canndoc's compelling financials, brands and trading on Nasdaq. Opportunity in GRAMF and other US players still trading at a discount. Learn more about your ad choices. Visit megaphone.fm/adchoices
SPAC Week II continues with Chris DeMuth Jr, Seeking Alpha Marketplace author and SPAC superstar. He discusses SPACs in general, cannabis SPACs in particular and his favorites with Rena Sherbill. What to look for in a SPAC, trading vs investing and why Chris likes Aphria and Canada. Learn more about your ad choices. Visit megaphone.fm/adchoices
SPAC Week returns with Joe Crouthers, Co-Founder and CEO of Ceres Group Holdings, who discusses with Rena Sherbill why they're focused on the plant-touching side of the sector. Tying cannabis into traditional business. SPACs more collaborative and less adversarial than traditional IPOs. What was irrational exuberance is now based on strong business foundations. The consumerification of cannabis. Learn more about your ad choices. Visit megaphone.fm/adchoices
The CBD market has recently seen a multi-billion dollar deal and HempFusion going public. HempFusion Co-Founder/CEO Dr. Jason Mitchell and CCO Danny Brody join Rena Sherbill to discuss radical transparency, methodical growth and becoming more efficient during Covid. We also cover the opportunity in probiotics and hemp. Doing things right as opposed to Right Away and why expansion is absolute. Learn more about your ad choices. Visit megaphone.fm/adchoices
In a troubling and unpredictable year, blockchain and cannabis have been some of the best investments and two industries most primed for growth. Chris Naprawa, Director and Chairman of the Board at Khiron and President at TAAL Distributed Information Technologies, shares his insights on both paradigm-shifting industries. Why BSV is the protocol of the future, and why TAAL is in position to capitalize on that. Importance of data. Solving for the consumer and regulatory compliance. Future of cannabis in South America, Brazil set to be biggest medical market, Colombia demographics an advantage and accessing capital at a cost you can live with. Learn more about your ad choices. Visit megaphone.fm/adchoices
Talking CBD, hemp, cannabinoids in the health and wellness segment with Smoke Wallin, CEO of Vertical Wellness. Many regulatory headwinds, but near-term hemp and CBD saturation will open up and level off. FDA still captive to pharma industry. Bigger opportunity for natural products industry. Essential to know how to operate in a regulated market. Cannabis beverages - bullish over long-term, many impediments short-term. Mutually beneficial consolidation, cannabinoids + athletes and the amazing results of chickens ingesting CBD. Learn more about your ad choices. Visit megaphone.fm/adchoices
CEO Jonathan Sandelman returns to the show to discuss AYR Strategies' recent deals and its steady rise to the top of the MSO pack. 7 M&A transactions in past 4 months. Very accretive deals for shareholders: great assets at a fair price. Want partners and shareholders to be excited to partner with AYR. AYR stock a big reason companies do deals with them. Importance of the flower. Why change in US political climate accelerated AYR's path for growth, what they like about Florida and where else they may be heading. Learn more about your ad choices. Visit megaphone.fm/adchoices
SPAC week continues with Kyle Detwiler, CEO of Clever Leaves, a recent entrant to Nasdaq. Building one of the largest cannabis companies in the world using a much more capital efficient funding process. going the SPAC route. Cannabis grown in Colombia, being GMP-certified, LatAm region makes sense especially for extraction use. Cannabis on a global stage. Learn more about your ad choices. Visit megaphone.fm/adchoices
It's SPAC week and why not start with Subversive Capital and the biggest cannabis SPAC ever, launching this week: The Parent Company. Subversive Founder and Chairman Michael Auerbach joins Rena Sherbill to discuss California as the tip of the spear and why it was always the focus. Creating a generational company and real change. Shared social equity vision with Jay-Z. Consolidating and dominating despite a saturated SPAC market. Being included in the chart topping ETF MSOS and why it's the best investment in cannabis right now. Learn more about your ad choices. Visit megaphone.fm/adchoices
Cannabis is reaching more people in more ways and recent US elections show the green rush is here to stay. But what about Canada? Jeff Fallows, President of The Valens Company, explains why he came on board - what they're doing differently and better than its Canadian peers. Cycle of improvement; operational efficiencies, better cost profile, leading the charge of cannabis 3.0 and next generation products. CPG companies getting into cannabis, inflection points and paying attention to share price. Learn more about your ad choices. Visit megaphone.fm/adchoices
Israel is the largest consumer of medical cannabis in the world, but regulatory progress towards full legalization is moving slowly.Saul Kaye, CEO and founder of iCAN, talks Israel's rapidly developing cannabis market and why regulators shouldn't forget the underground market. Setting up supply chains in Israel and Europe. Psychedelics, cannabis and treating mental health. Learn more about your ad choices. Visit megaphone.fm/adchoices
Our Master Class returns with two terrific SA authors and investors in the cannabis space: James V. Baker and Julian Lin. We cover the US cannabis space and why P/E multiples don't make any sense; out of whack valuations. Coming soon: 100 bagger stocks; issuing debt vs selling stock. Cannabis investors need to be better educated. the absurdity of 280E. Covering the ETF MSOS, derivatives and options and a basket approach to cannabis investing. Learn more about your ad choices. Visit megaphone.fm/adchoices
Columbia Care CEO and co-founder Nicholas Vita shares his thoughts on disproportionate growth, and why private equity may be the next big thing to get into cannabis. State laws dictate federal laws, which has only been exacerbated by Covid. Columbia Care is the leader in the Mid-Atlantic and readying for staggering growth in the East Coast. Headlines are great but integration is hard, driving real value requires real discipline. Market leader in most of their markets in multiple states because they've had more time to do it. Learn more about your ad choices. Visit megaphone.fm/adchoices
We are on the cusp of another burst of M&A in the cannabis industry, but one grounded more in fiscal responsibilities. Scott Hammon, partner and leader of the cannabis practice at MGO, joins Rena Sherbill to discuss this trend amidst the rapidly maturing cannabis industry. We also cover why companies are putting a stronger emphasis on regional footprints over a national one; good operators will be able to take advantage of this market no matter size or business model. Learn more about your ad choices. Visit megaphone.fm/adchoices
Celebrating our 100th episode! Alvaro Torres, co-founder and CEO of Khiron, joins us to discuss building value in LatAm and Europe and why a strong foundation is essential. Following its recent Q3 earnings and some bullish announcements, we also cover why Khiron wanted to avoid treating cannabis as a commodity. Sustainable patient growth with good margins. Staying the course. Slow, but present, European growth; CBD skincare in Hong Kong; growth in Mexico, Colombia and beyond. Learn more about your ad choices. Visit megaphone.fm/adchoices
Fresh off record earnings, Planet 13 continues to build on investors' excitement about cannabis in general and the US in particular. Co-CEO Bob Groesbeck talks to Rena Sherbill about being positioned for growth once more markets open up and protecting margins, the importance of liquidity and avoiding debt. Fighting for reform. Experiential retail. Encouraged by the critical mass of the States and hoping to see a bill soon that acknowledges that. Visions of dividends. Learn more about your ad choices. Visit megaphone.fm/adchoices
MSOhmy! The US cannabis space is at least 10x the size of Canadian market - and growing. Recent earnings for cannabis companies bear this out in a tale of two countries, with the US winning. Dan Ahrens, AdvisorShares COO and PM, returns to the show to discuss why stock selection matters, index based doesn't make sense for cannabis and avoiding Canada with exception. Cannabis ballot initiatives passing easily and broadly in US - upside is huge. The false narrative of popping stocks. Learn more about your ad choices. Visit megaphone.fm/adchoices
During a recessionary environment is historically when VCs make a ton of money. Narbe Alexandrian, President and CEO of Canopy Rivers, the venture capital arm of Canopy Growth, returns to the show. We discuss its portfolio, TerrAscend capitalizing on New Jersey going legal, and building one's thesis in the cannabis market. We also cover creating brand equity, being customer obsessed and finding the disruptors. Pushing edibles to the next level with automation and why most companies wouldn't choose vertical integration unless they had to. Learn more about your ad choices. Visit megaphone.fm/adchoices
For cannabis legislation, worth focusing less on Presidential election, more on the Senate. Majority of Americans support cannabis legalization - what other topic has such unified opinion? So asks Anthony Coniglio, CEO of NewLake Capital, a cannabis real-estate investment vehicle with tenants across the supply chain in the U.S. We discuss the value of real estate, how NewLake differs from IIPR and why we'll continue to see single state operators get bought by MSOs. Focusing but not obsessing over politics and regulatory authorities. Change, no matter what, is slow. Learn more about your ad choices. Visit megaphone.fm/adchoices
Today's guest is the co-founder, CEO and CIO of Cambria Investment Management, Meb Faber. He has authored numerous white papers and books on factor-based portfolio construction and favors value- and momentum-tilted strategies in Cambria's 12 ETFs, as well as in the firm's separately managed accounts. The Cambria Cannabis ETF (TOKE) is currently Cambria's only foray into thematic investing - which says a lot about Faber's strong belief in the Cannabis sector's long-term prospects. At 42 basis points, TOKE is the cheapest way to gain exposure to the growing Cannabis sector. Is it also the best? Show Notes
1:45 - Covid-19 and Meb's work/life balance
5:45 - Why Meb decided to start his own ETF firm; General philosophy on launching ETFs
11:15 - Given how saturated the Cannabis fund space is, why make that Cambria's first thematic ETF?
18:30 - As a value guy, are Cannabis sector valuations currently reasonable?
24:00 - How important is U.S. federal legalization to the long case for cannabis stocks?
Learn more about your ad choices. Visit megaphone.fm/adchoices
We know not all states have legal cannabis and taxes are still being spent to keep people in jail for cannabis charges - and while there is extreme wealth in the industry not enough is being done to create change. Stormy Simon - after a successful 15 years at Overstock.com - opened her eyes to the power of the cannabis plant - and after a stint as High Times' CEO - decided to run for Utah's House of Representatives. We discuss the importance of active participation, moving towards plant medicine, and disrupting the system with blockchain. Learn more about your ad choices. Visit megaphone.fm/adchoices
As the cannabis industry continues to mature, many companies are reckoning with necessary evolutions. George Allen, formerly of Acreage and a friend of the show, joins Rena Sherbill to discuss the MSO scene and some of the myths surrounding the US cannabis industry. George always liked Indus Holdings' assets, but the company had made some mistakes before he came on board. Now it's operating at an enviable scale. We discuss why Indus has a real chance at being the leading player in California. Simplicity of mission most essential. Learn more about your ad choices. Visit megaphone.fm/adchoices
Marie Montmarquet, co-founder of MD Numbers, talks to Rena Sherbill about the advantages of running a small family business. Avoiding over-corporatization, staying focused on the details, but knowing partnership may be inevitable. We also discuss the differences between Northern and Southern California cannabis cultures, willful vs woeful ignorance, failed policies and unavoidable unfriendly loans in the cannabis industry. Self-funding, maintaining and raising capital as a minority and first business owner. Fighting for real social equity programs - pessimistic on macro level; optimistic on a community level. Learn more about your ad choices. Visit megaphone.fm/adchoices
Frustrated by the 'business of medicine', Dr. Jessica Knox co-founded Doctors Knox, Inc., American Cannabinoid Clinics, and ADVENT Academy in order to build an endocannabinoidome care ecosystem that is science-based, patient-focused, and equity-driven. Dr. Knox joins Rena Sherbill to discuss the importance of leading with history and science, the concern around rescheduling cannabis and why the bifurcation of medical and rec/adult use market doesn't make sense. Misinformation and stigma still deeply entrenched in the medical community. Single molecule medicine and issues around incorporating whole plant cannabis medicine. Learn more about your ad choices. Visit megaphone.fm/adchoices
Max Simon, a cannabis thought leader, founder and CEO of Green Flower Media joins Rena Sherbill to discuss our favorite green flower. We discuss improving quality of life through cannabis, the job growth in the industry, running cannabis companies like a CPG company and why 'what cannabis stock should I buy' isn't the right question. We also cover the power of education and destigmatizing the cannabis plant. Learn more about your ad choices. Visit megaphone.fm/adchoices
With only 2 states, AYR Strategies is a top 5 EBITDA company and from a profit margin perspective, second in the industry. We're now in cannabis 2.0 which means more discipline from companies and investors. The winners have access to capital, bit everyone else is excluded. Jon Sandelman, AYR's CEO, returns to the show discuss with Rena Sherbill why culture and vision matter and why you can't build a big business on a weak foundation. We also talk about the currency of current deals in the space, the death spiral of dilution, and CPG multiples. Learn more about your ad choices. Visit megaphone.fm/adchoices
Though much of the US and Canadian cannabis space is focused on the adult-use/rec market, Africa, Europe, and Asia (most of the world!) are more focused on the medical side and that's where the legal industry is being established. David Parry, CEO of Cannsun Medhel, joins the show to talk about the medical side of cannabis, and focusing on Asia, Europe and Africa. Learning from indigenous communities about complements to THC and CBD. Integrating business with community, righting social equity wrongs, sustainably using stalks and roots, pushing back against traditional pharma and building a good seed bank in Africa and Thailand. Learn more about your ad choices. Visit megaphone.fm/adchoices
We cover many fundamental questions in this deep, broad and colorful conversation with two terrific Seeking Alpha authors and investors in the cannabis space: James V. Baker and Julian Lin. Why there is time for current MSOs to build a moat, importance of passing MORE Act, descheduling the plant and why getting rid of 280E gives the industry life. Fallacy of free cash flow, MSO rollups, generating profits without economies of scale. Thoughts on Green Thumb-Trulieve rumors and why momentum investors will get shaken out. Learn more about your ad choices. Visit megaphone.fm/adchoices
Many companies try and get away from the stoner side of cannabis; Scott Sundvor and Space Coyote lean into it. Importance of being focused on profit from the beginning while respecting the plant and consumer. Many great companies have risen from great recessions. 2020 the year of survival. Thoughts on cultivation, natural selection in the cannabis space, getting away from venture dollars and learning the lessons of Covid. Favorite strains and joint rolling tips! Learn more about your ad choices. Visit megaphone.fm/adchoices
Trulieve recently reported earnings and is getting a lot of shareholder love - we take a deeper dive into the numbers in a frank conversation with CEO Kim Rivers. We talk growth despite onerous banking regulations, incremental momentum on 280E, why discipline matters and building a hub model across the US. We also discuss issuing debt and the salient lesson that capital markets aren't always available so can't rely on them to run your business. Learn more about your ad choices. Visit megaphone.fm/adchoices
Everyone agrees that cannabis in the 21st century is far different than cannabis of the past - much of that has to do with terpenes. Chris Campagna, CEO of True Terpenes, joins Rena Sherbill to discuss well, terpenes, and the entourage effect. We also cover taking a different approach to medicine than traditional pharma, the future of inter-state cannabis commerce - challenges of getting genetics from state to state when the plant is still illegal; evolution of testing, edibles and improving cannabis beverages. Learn more about your ad choices. Visit megaphone.fm/adchoices
We're in a small business crisis - now is the time to pick up distressed assets. Matt Hawkins, founder of Entourage Effect Capital, joins Rena Sherbill to discuss opportunities for distressed investing, why this time has been great for the cannabis industry and drifting towards real growth opportunities in edibles and liquids. We also talk legalization as the next big wave, why flower isn't going anywhere, creating scale with new investments, politicization of safe banking and toxic optimism. Learn more about your ad choices. Visit megaphone.fm/adchoices
Dr. Ethan Russo and Dale Hunt, PhD - superstars in the cannabis space - join Rena Sherbill to discuss why the cannabis plant is a biochemical treasure trove that we've only just begun to understand. We cover endocannabinoids, body receptors, the entourage effect on a molecular level, and why we're at the frontier of the future of medicine. We also discuss them teaming up to create Breeder's Best, and why it's essential for breeders to have a seat at the table. Learn more about your ad choices. Visit megaphone.fm/adchoices
Exploring more about the medical/pharma side of cannabis sector and thematic ETF investing. Rahul Bhushan is co-founder of Rize ETF and joins Rena Sherbill to discuss when passive makes more sense than active management, low fees and transparency. Europe's funds and cannabis market vs US and Canada, preferring CBD to THC, R&D of other cannabinoids, ancillary players and the 3 waves of the cannabis industry. Learn more about your ad choices. Visit megaphone.fm/adchoices
With the U.S. economy reeling as a result of the COVID-19 pandemic, tax revenue is likely to have fallen precipitously for FY2020. Combine that with changing social attitudes towards cannabis and the upcoming U.S. election and you may just have the "perfect storm" for legalization on the federal level. Global X CEO Luis Berruga joins The Cannabis Investing Podcast to explain how his firm's ETF (POTX) provides investors the opportunity to capitalize on the potential for federal legalization. And even if federal legalization doesn't become a reality in 2021, Berruga still sees plenty of upside for publicly-traded cannabis stocks with increasing numbers of state likely to legalize. Show Notes
2:30 - A most elegant piece of financial engineering: What drew Luis to the ETF space?
6:00 - A Perfect Storm: Will COVID-19 economic pain finally provide the impetus for federally legal cannabis in the U.S.?
10:00 - The upcoming U.S. election: What different potential outcomes are likely to say about the prospects for legalization
12:30 - Growth potential without U.S. federal legalization?
15:15 - A consumer staple: Will cannabis' strongest growth lever be on the recreational or medical side of the business?
19:30 - Are today's cannabis industry leaders still likely to be leaders in a decade's time?
24:00 - Under the hood: POTX holdings and indexing methodology
Learn more about your ad choices. Visit megaphone.fm/adchoices
Cannabis stocks are a good deal right now - don't be afraid to put more money in. That's what Ted Waller, esteemed Seeking Alpha contributor, 50 year market veteran and cannabis investor, says. We agree! We also discuss how to know when to pull the trigger on a stock, favoring the extraction model going forward (oils over flower), ETFs vs. stocks, MJ's dividend and Ted's top picks in the space. Learn more about your ad choices. Visit megaphone.fm/adchoices
Talk to most successful cannabis investors and one of their top picks is likely to be Trulieve, the leading medical cannabis company in Florida. The company boasts strong financial performance and profitability in an industry still suffering from a capital crunch and inexperienced executives. Kim Rivers, CEO of Trulieve, returns to the show to discuss the necessity of passing banking regulations, Covid legislation and lessons we can learn from prohibition and the Great Depression. We also cover the incredible catalyst that is edibles in Florida, moving into Massachusetts, uplisting to a major US exchange and choosing responsible growth. Learn more about your ad choices. Visit megaphone.fm/adchoices
Mike Donnelly is a former Navy SEAL who, with his wife Claudia, founded a hemp-derived CBD company focused on giving back to the veteran community. He joins Rena Sherbill to discuss the saturation of the market, why CBD is especially good for dogs and the wonders of cannabinoids. They also talk about building the American Dream, starting a 501(c)(3) for veterans and why no one's actually buying CBD from Amazon. Learn more about your ad choices. Visit megaphone.fm/adchoices
How do you know which cannabis stocks to buy? Nicholas Gastevich, co-owner of a family firm in Chicago that invested early in the Illinois cannabis space, helps guide us. Why he likes Green Thumb Industries, Cresco, and his top 4 picks in the sector. We also cover the recent Canopy/Acreage deal, iAnthus' debt, excessive executive compensation and being greedy with shareholder money. We also discuss why many management changes are overblown, adjusted EBITDA and Illinois' once promising social equity program model. Learn more about your ad choices. Visit megaphone.fm/adchoices
Uruguay was the first country to legalize cannabis and where Kevin Nafte and Andrea Krell, married co-founders of YVY Life Sciences, decided to plant their sustainable, organic cannabis company. They join Rena Sherbill to discuss why problematic banking for cannabis companies exists in Uruguay, what to expect this year from Latin America, and the benefits of having Facundo Garretón on board. They also cover having to del with regulatory roll out despite legalization, teaching cannabis cultivation to farmers, and the benefits of rich soil and agricultural innovation. Learn more about your ad choices. Visit megaphone.fm/adchoices
As the cannabis industry matures, investors are looking for companies that are either already profitable (only a couple fit the bill) or at least on the right path. Barry Fishman, CEO at Vivo Cannabis, talks to Rena Sherbill about their path to profitability, focusing on Canada, Germany and Australia and his view on the necessity of debt. We also cover what they look for in M&A targets, why they're not focusing on the US, social equity in the industry, and the challenges COVID brings. Learn more about your ad choices. Visit megaphone.fm/adchoices
Derek Du Chesne, President and Chief Growth Officer at Exactus, a company that recently pivoted into the hemp space, tells Rena Sherbill why he's looking forward to industry consolidation. We also discuss what's going to drive exponential growth in the hemp and cannabinoid industry, discovering how different cannabinoids affect us and why CBD is just the tip of the iceberg. Given his background in entertainment, we also discuss why making a movie is like creating a start up, hemp genetics and why genetics are a trust purchase. We also cover China, how it's substantially ahead in hemp manufacturing, but has very little related to cannabinoids, hemp farming methodology, and why high prices hinder industry growth. Learn more about your ad choices. Visit megaphone.fm/adchoices
Between hemp and marijuana, the difference is a legal one: how much THC is allowed in the plant. But it's all cannabis. Hemp has mostly been used for industry and nutrition, but that's changing. Morris Beegle joins Rena Sherbill to discuss the shift from industrial hemp to cannabinoid hemp and why the investment play is on the fiber and grain side. We also cover the potential and power of hemp and the various ingredients it can create throughout many diverse sectors. Learn more about your ad choices. Visit megaphone.fm/adchoices
What does it take to scale U.S. regional cannabis brands and do so profitably? Rena Sherbill talks to two regional cannabis brands, Aviv Hadar from Oregrown and Eric Ross and Ed Weidenfeld of District Cannabis and Phyto Management. One from the Pacific Northwest, in Oregon and one from the East Coast in Washington DC/Maryland. Their issues with MSOs, why one believes in vertical integration and the other doesn't. We also discuss why balance sheets are just as important as income statements, the mistaken emphasis on rapid growth over revenue or profit, the impact of 280E, and 'The Canada Scam'. Learn more about your ad choices. Visit megaphone.fm/adchoices
Volatility is back in the cannabis market. Rena Sherbill talks about the state of the cannabis industry during and beyond COVID with Sally Nichols, long-time investor and current President Sales & Distribution, CBD at Bloom Farms. We also cover why overtaxing bifurcates the industry, the importance of building visibility, and anticipating market shifts. We also discuss the language of transaction and why it's difficult for bigger brands across state lines to build consistency and dependability. Learn more about your ad choices. Visit megaphone.fm/adchoices
Special Flower Friday edition with Danny Murr-Sloat, owner of AlpinStash, a revered craft grower and cannabis breeder in Colorado. He joins Rena Sherbill to discuss best practices for growing high-quality flower and whether large scale grows can achieve that quality. We also cover the regulatory picture in Colorado and the States, similarities between craft beer and cannabis and why the future of cannabis retail just might involve pinball machines. Learn more about your ad choices. Visit megaphone.fm/adchoices
Many cannabis stocks continue their rise, while some continue their fall. How do investors know who to bet on? Jon Sandelman, CEO of AYR Strategies, a cash positive US MSO, talks about living through crashes, Covid forcing consolidation and the importance of disciplined financials. We also discuss millenials preferring cannabis to beer; sale leaseback debt, building your edge in the industry, corporate culture and momentum driven capital. Learn more about your ad choices. Visit megaphone.fm/adchoices
Cannabis stocks continue their climb this week and look to be in the same category as other recession proof industries. Rena Sherbill talks to Howard Lee, CEO of Sorse Technologies about the medical possibilities in CBD emulsion, partnering with Pascal Biosciences, and the innovation and opportunity that lured him to cannabis. We also discuss what shape the U.S. recovery will have, creating a 'businessman's high', doubling revenue every year, why it's easier for cannabis business to pivot in this climate and the importance of giving back during COVID. Learn more about your ad choices. Visit megaphone.fm/adchoices
Cannabis stocks have been soaring this week - obliterating short sellers and giving hope to cannabis investors after a tough year. Julia Jacobson, CEO of Aster Farms, talks to us about how retail taught her about understanding volatility and the importance of holding prices through a recession. We also cover how COVID affects supply chains, building a sustainable brand, the role of smaller farms in the ecosystem and why venture funding may be on hold until Q4 or later. Learn more about your ad choices. Visit megaphone.fm/adchoices
After decades of long/short equity investing for hedge funds on the sell side, Mike Regan switched to covering the cannabis space for MJBizDaily. He joins Rena Sherbill to discuss the similarities between the internet bubble and the cannabis market today and what we can glean from those bubble valuations. We also cover why capital structure is key, vertical integration in nascent industries, understanding margin potential, cannabis in Canada vs. US, and the challenges in the CBD market. Learn more about your ad choices. Visit megaphone.fm/adchoices
Happy 4/20/20! We talk today with Andrew DeAngelo, co-founder of Harborside, which recently went public on the CSE and the first cannabis dispensary to receive a legal license. We discuss why cannabis companies are so good in a crisis, being laser focused on profitability even in this market cycle and why the politics of cannabis can be so frustrating. We also cover why this is the time to improve as leaders and companies and absorb the deep teaching moment from COVID. Learn more about your ad choices. Visit megaphone.fm/adchoices
Is COVID good for cannabis companies? Is cannabis good for COVID? And what happens when plans to go public are derailed? We cover all this and more with Garyn Angel, CEO and founder of Magical Brands which produced the first self-contained herbal extraction device for at-home use. We also discuss edibles and other non-smokeable products during COVID; the importance of taking market share now and why this will be a V shaped recovery. Market capitulation, share dilution and why you shouldn't be concerned about missing the last 15% of a market bottom. Also - the first 6 listeners to send us a comment will receive a free machine giveaway from Garyn and Magical Brands! Learn more about your ad choices. Visit megaphone.fm/adchoices
Nasdaq listed Cadiz took advantage of the 2018 Farm Bill and is now growing hemp thanks to its recent JV with Glass House, one of the largest privately held, vertically-integrated, eco-friendly cannabis and hemp companies in the world. Scott Slater, CEO and President at Cadiz and Graham Farrar, CEO at Glass House Farms join the show to discuss their unique and complementary partnership. We also cover why not all CBD is hype, leading a company during COVID, the business of selling crops and why Cadiz is confident about its cash position and bullish on its prospects. Learn more about your ad choices. Visit megaphone.fm/adchoices
With the world in lockdown, cannabis sales are surging in most states, but with massive unemployment, will that continue? Rena Sherbill talks to Jason White, CMO at Curaleaf, one of the biggest MSOs with $1 billion in annual sales in its sights. They cover the importance of knowing when to partner with an expert and when to expand a company's own offering, building brand synergy and how CURLF is innovating more products and strengthening its national footprint. Learn more about your ad choices. Visit megaphone.fm/adchoices
Cannabis stocks have been generally up this week, and are even outperforming the S&P 500 - but we're also seeing management shakeups, layoffs and supply chain disruption. Bruce Linton, industry trailblazer and executive chairman at Vireo Health, shares his insights into the sector in the time of this global pandemic. We also cover why Bruce chose Vireo after Canopy, his unique access to capital and why now is actually the best time to make the company stronger though accretive acquisitions. Learn more about your ad choices. Visit megaphone.fm/adchoices
As the founder of white label ETF issuer Nottingham Funds, Kip Meadows has developed real expertise in key areas of the ETF space - particularly in Cannabis Investing, where his firm has been the force behind several ETF launches (THCX) (CNBS). Kip walks listeners through the dos and don'ts of Cannabis ETF investing on the latest episode of The Cannabis Investing Podcast. Show Notes
3:00 - Explanation of the "back office" side of the ETF business
4:30 - The white label fund launch process
7:00 - What do investors interested in investing in cannabis funds need to look out for?
11:00 - What's better in the cannabis space: active management or passive index funds?
13:30 - What industry is a good comparison to the cannabis industry?
17:30 - What are major challenges in the space right now?
20:00 - Do we need to see U.S. legalization to see a run up in the sector's stock prices?
Learn more about your ad choices. Visit megaphone.fm/adchoices
How do you decide which stocks to pick in the cannabis market? How do you navigate the sector downturn? Oren Benoff, who manages a family fund focused on cannabis stocks, joins Rena Sherbill and gives his frank assessment on which MSOs stand out, what is lacking in Canada and the advantage of companies catering to women and seniors. We also discuss the burgeoning market which will eventually take over $341 billion global black market and cover knowing when to sell a stock. Learn more about your ad choices. Visit megaphone.fm/adchoices
Shiry Eden is CEO and founder of Nishot, an Israeli advisory firm focused on the global cannabis industry. She joins Rena Sherbill to discuss the domestic cannabis market in Israel, its role in the international markets and why Israeli cannabis companies are similar to Canadian small caps. We also cover why her fund is 90% invested in North American stocks, multi-state vs. multi-continent operators, her thoughts on the ETF space and why she's worried about Aurora but excited about Aphria and Trulieve. Learn more about your ad choices. Visit megaphone.fm/adchoices
Roger Volodarsky is founder and CEO of Puffco, an award-winning company that sees concentrates as the future of cannabis consumption. He joins Rena Sherbill to discuss scaling while failing, what it takes to be a successful and humane leader and the lessons of starting a business from nothing. We also cover chasing innovation, the state of the vaping industry, why Puffco focuses on concentrates and why they moved their business to California. Learn more about your ad choices. Visit megaphone.fm/adchoices
George Allen is the former President of Acreage Holdings, founder of Geronimo Capital, and has extensive experience in finance and investment. He joins Rena Sherbill to discuss his decision to leave Acreage after its merger with Canopy and why he believes that merger will still go through. We also cover why Trump may deschedule cannabis before the election, the embarrassing execution of some U.S. players, and why it's not yet time for the casual investor to get into the space. Learn more about your ad choices. Visit megaphone.fm/adchoices
Wassef Tawachi is co-founder and CEO of Ciencia Labs, a California based manufacturer of science-forward cannabis products and brands. He joins Rena Sherbill to discuss getting in at the height of cannabis fervor, avoiding career burnout and CBD bearishness. We also cover the science of cannabis, how to build a successful brand in a saturated space and the unique advantages and disadvantages of the California market. Learn more about your ad choices. Visit megaphone.fm/adchoices
Jeff Mascio is CEO of Cannabis One Holdings. Jeff has worked at Smith Barney and Merrill Lynch as well as a fund manager, and was President of Meridian Capital Advisors. He joins Rena Sherbill to discuss being in a capital intensive industry using a franchise business model and the expectation that cannabis will be descheduled before the U.S. Presidential election. We also cover accretive acquisitions, depressed valuations, lingering unknowns in Canada and why Mexico looks so promising. Learn more about your ad choices. Visit megaphone.fm/adchoices
Rudi Schiebel is CEO & Founder of Habitat Life, a cannabis micro-cultivator that’s focused on regenerative agriculture and sustainable protein. He joins Rena Sherbill to discuss smaller producers focusing on high quality and craft production - what sophisticated consumers are looking for and what's missing from the marketplace. We also cover the hurdles of Health Canada's regulatory limitations on packaging and advertising and the optimism of U.S. going federally legal. Learn more about your ad choices. Visit megaphone.fm/adchoices
Kim Rivers is CEO of Trulieve, a vertically-integrated multi-state operator based in Florida and one of the few profitable cannabis companies. Kim joins Rena Sherbill to talk financial discipline, mindful expansion and the precedent Trulieve is trying to set by suing a short seller for libel. They also discuss the importance of female mentorship, the inevitability of descheduled cannabis and why what happens in the Northeast will be telling for the rest of the country. Learn more about your ad choices. Visit megaphone.fm/adchoices
Debra Borchardt, CEO, Co-founder and Editor-in-Chief of cannabis financial news site Green Market Report, joins us for our 50th episode to discuss the state of the cannabis market. We cover the disruptive possibility of the US descheduling cannabis, the state of the US, Canadian and international markets. We also discuss why Debra's bullish on Trulieve despite short report, as well as Cresco Labs, Green Thumb Industries and Acreage Holdings. Learn more about your ad choices. Visit megaphone.fm/adchoices
Kevin Shin is the CEO of Grove Group Management, a firm he co-founded with Tiki Barber that’s focused on launching and building the most innovative businesses in the cannabis industry. Kevin has over 17 years of experience in the finance industry and joins Rena Sherbill today to discuss partnering with celebrities, why cultivation is on the decline and why regulations need more federal oversight. We also discuss the near and long-term picture in the sector, when vertical integration makes senses and the overvaluation of the industry. Learn more about your ad choices. Visit megaphone.fm/adchoices
Javier Hasse is the author of the book Start Your Own Cannabis Business and an award-winning reporter and editor who focuses on the cannabis space as well as a Billboard-charting rapper. He joins Rena Sherbill to discuss getting into the industry by chance, his thoughts on the space going into 2020, and why he's bullish on cannabis as a whole. We also cover the global cannabis landscape, how the US is similar to the EU, why regulatory implementation is always very complex and why you shouldn't totally count out Canadian LPs. Plus, we drop our year end rap! Learn more about your ad choices. Visit megaphone.fm/adchoices
Alan Brochstein, our first repeat guest, is the founder of 420 Investor and New Cannabis Ventures, a curated and original content site that focuses solely on the cannabis space. He joins the show today to discuss the year that was in cannabis and his outlook for 2020. We also cover his concerns over the industry's capital crunch, why MSOs are doing better than Canadian LPs and why the CBD/hemp market is more concerning than exciting right now. Learn more about your ad choices. Visit megaphone.fm/adchoices
Amy Margolis is the Founder and Program Director of The Initiative, an accelerator program designed for women cannabis entrepreneurs and executives. Amy has been a practicing attorney for 18 years, regularly representing cannabis growers and founded the Oregon Cannabis Association and The Commune, Portland’s first cannabis gathering space for cannabis businesses. Amy joins Rena Sherbill to discuss what's keeping institutional investors out of the space, Oregon's cannabis market, and overcoming disingenuous responses to women-led businesses. We also cover why smaller, well funded plays may be more advantageous than MSOs and why Amy's not overly optimistic about the SAFE Banking Act passing the Senate. Learn more about your ad choices. Visit megaphone.fm/adchoices
Marshall Getto is CEO of Freed Technology, a California based organic CBD company. He joins Rena Sherbill to discuss the present confusion in the THC, CBD and vaping markets and the high margins that currently exist in the CBD market. They also cover what it takes for successful packaging and branding, the importance of clean products and the global CBD market. Learn more about your ad choices. Visit megaphone.fm/adchoices
Nicole Fox is founder and CEO of AEON Botanika, a wellness cannabis company in LA, and has been a cannabis activist since 2003. She co-founded two of the first dispensaries in LA, serves on the board for Southern California Coalition, is a registered dietitian, and has background in functional and integrative medicine. She joins Rena Sherbill to discuss why the cannabis industry is like building an airplane while flying it, the advantages of micro-dosing THC especially for women and older adults and why she pivoted into retail and wellness. We also cover federal descheduling, why packaging and branding must have a quality product, and the lack of knowledge around CBD and hemp. Learn more about your ad choices. Visit megaphone.fm/adchoices
Discussing the hemp/CBD and cannabis markets with two sector experts. Josh Drayton is Communications and Outreach Director of the California Cannabis Industry Association, an association that collectively represents over 460 industry businesses. Alex Seleznov is a board member and treasurer for the National Hemp Association as well as founder of Advanced Extraction, a company specializing in organically produced hemp products. They join Rena Sherbill to discuss the vaping crisis, California as a model for legalization and what it means to be a player in the current CBD space. Learn more about your ad choices. Visit megaphone.fm/adchoices
Patricia Heer is Editor and co-founder of Cannabis Law Digest, an online platform of legal resources for the cannabis industry. With her extensive litigation and commercial experience, Patricia joins Rena Sherbill to break down the convoluted legal landscape in the cannabis industry. They also discuss why advocates have a problem with the SAFE Banking Act, the impediments to wide-spread legalization and the best ways for companies to navigate regulations. Learn more about your ad choices. Visit megaphone.fm/adchoices
Fabian Henry is founder and director of Breton CannaPharms and president and founder of Global Alliance Foundation Fund, which helps veterans recover from trauma. Fabian was recently featured in the documentary Unprescribed, which looks at medical marijuana as a treatment for PTSD and a means for combating veteran suicides and helping them return home from combat. On Veteran's Day, he joins Rena Sherbill to discuss why cannabis is the best medicine for trauma, the frustrating reality of legalized cannabis in Canada and the 4 pillars of treatment. Learn more about your ad choices. Visit megaphone.fm/adchoices
Chuck Smith is the President and CEO for Dixie Brands, a multi-state operator and the parent company of the Dixie and Synergy brands. He joins Rudy Hernandez to discuss the importance of banking access, building a company culture and the responsibility of brands to the industry. We also cover why the cannabis industry is only in the first inning and why investors need to be in it for the long haul. Learn more about your ad choices. Visit megaphone.fm/adchoices
Irwin Simon is Chairman and interim-CEO of Aphria, which produces and sells medical cannabis in Canada and internationally. Prior to joining Aphria, Irwin founded Hain Celestial, a leading organic and natural products company which he ran for more than 25 years. He joins Rena Sherbill to discuss the similarities between the cannabis and health & wellness space, why profitability is so important and why he doesn't think the U.S. will go completely federally legal. Learn more about your ad choices. Visit megaphone.fm/adchoices
Steve White is CEO and co-founder of Harvest Health & Recreation, a vertically integrated publicly traded cannabis company with one of the largest footprints in the US. Steve co-founded Harvest in 2011 and prior to that he worked as an attorney. Under Steve’s direction, Harvest has engaged in many community activities and events, including hosting a new patient orientation and monthly support group. He joins Rena Sherbill to discuss the SAFE Banking Act, targeted acquisitions, the importance of remaining agile and why it may be impossible to not run afoul of cannabis regulations. Learn more about your ad choices. Visit megaphone.fm/adchoices
Garvis Toler was recently named president of data services at Helix TCS, a publicly traded cannabis technology provider. Previously, Garvis was the global head of capital markets at the New York Stock Exchange. He joins Rena Sherbill to talk about harnessing and commercializing a decade worth of data and Helix's focus on acquisitions and organic growth. We also discuss volatility in the sector, communicating with investors and what cannabis players can learn from the dotcom era. Learn more about your ad choices. Visit megaphone.fm/adchoices
Ken Villazor is President and CEO of Flower One Holdings, a publicly traded cannabis company. Ken joins Rena Sherbill to discuss what differentiates Flower One from other U.S. focused cannabis companies, what other states and countries can learn from Nevada's successful regulatory program, the decision to focus on price and yield, and why - if anything - the market's only getting stronger. Learn more about your ad choices. Visit megaphone.fm/adchoices
Today's guest on Seeking Alpha's Cannabis Investing Podcast is Tim Seymour, of CNBC Fast Money fame. Tim was an early stage investor and recognized voice in the cannabis industry. He recently launched an actively managed pure play Cannabis ETF, the Amplify Seymour Cannabis ETF (CNBS), where he serves as Portfolio Manager. During this conversation, Tim weighs in on key macro trends affecting cannabis investors, while also providing a detailed and intimate perspective on a dozen companies in the space. Learn more about your ad choices. Visit megaphone.fm/adchoices
Noa Kahner is founder of Kahner Global, which produces investment conferences, including The Cannabis Private Investment Summit Series. Noa joins Rena Sherbill to discuss institutional investors in the cannabis space and the evolution of the industry. They also cover why investing in cannabis is different than any other industry and the importance of thinking strategically. Learn more about your ad choices. Visit megaphone.fm/adchoices
This trailer previews our initial two shows on The Investing Edge, from Value Investor's Edge Live hosted by J Mintzmyer, and The Razor's Edge, hosted by Daniel Shvartsman and Akram's Razor.
Our excerpt for Value Investor's Edge Live is from our first episode, where J Mintzmyer speaks with Robert Bugbee of Scorpio Tankers about the company's comfortable cash position and the pending catalyst of IMO 2020.
Our excerpt from The Razor's Edge is from the first episode, which covers Disney, Netlfix, and the streaming universe. Daniel Shvartsman asks Akram's Razor about whether Netflix can solve a budding challenge - too much content on the service.
The Investing Edge is a podcast channel on Seeking Alpha that features shows from different Seeking Alpha authors, with a focus on their unique investing style. Authors will speak with CEOs and industry experts, break down key market stories and topics, and share insights on how they research new investments.
The first two shows on The Investing Edge are:
Value Investor's Edge Live, hosted by J Mintzmyer of Value Investor's Edge. The show will feature J's conversations with publicly traded shipping company CEOs, sector experts, and fellow deep value investors about their companies and investing approaches.
The Razor's Edge, hosted by SA podcast host Daniel Shvartsman and Seeking Alpha author Akram's Razor of The Razor's Edge. Learn more about your ad choices. Visit megaphone.fm/adchoices
Greg Marco is President of Leading Edge Expositions, which produces the CWCBExpo, a B2B trade show event for the legalized cannabis industry. He joins Rena Sherbill to discuss the regulatory challenges of putting on a cannabis conference and how the East Coast conferences vary from the mature markets on the West Coast. They also discuss the importance of branding, why packaging and labelling are huge, and what the next couple years may look like in the industry. Learn more about your ad choices. Visit megaphone.fm/adchoices
Debra Borchardt is CEO, co-founder and Editor-in-Chief of the cannabis financial news website Green Market Report. Debra joins Rena Sherbill to discuss the evolution of the industry, the future of cannabis retail and what to focus on when choosing a cannabis ETF. We also discuss Debra's Green Market Summit happening this week and why it's focusing on the economics of cannabis brands. Learn more about your ad choices. Visit megaphone.fm/adchoices
Ronan Levy is Chief Strategy Officer at Trait Biosciences, a cannabis biotech firm. Prior to joining Trait, Ronan served as Senior Vice President of Business and Corporate Affairs at Aurora Cannabis. He joins Rena Sherbill to discuss the extreme growth the sector has seen and why big companies should be focused on market share over profitability. They also cover the commoditization of cannabis production, focusing on minor cannabinoids and why increasing yields and lowering costs are low hanging fruits. Learn more about your ad choices. Visit megaphone.fm/adchoices
Joe Lusardi is President & CEO of Curaleaf, a vertically integrated multi-state cannabis operator in the U.S. He joins Rena Sherbill to discuss the growth trajectory of the industry, vertical integration as a means to control supply and quality of product. They also cover Curaleaf's recent big-name acquisitions, the need to focus on developing brands and why their in-depth earnings call is a point of differentiation in the industry. Learn more about your ad choices. Visit megaphone.fm/adchoices
David Sandelman is Chief Engineer at Cannatrol, a precision drying/curing system for cannabis. He joins Rena Sherbill to discuss the similarities between drying and curing meat, cheese and cannabis. They also discuss the sector's resistance to new technology and how his invention helps control humidity in the flower. Learn more about your ad choices. Visit megaphone.fm/adchoices
David Brough is CEO of Klonetics Plant Science and has had extensive experience in the oil and gas industry. He joins Rena Sherbill to discuss getting more profitability from growers and creating new strains with world-class breeders. They also discussed tissue culture technology, international expansion and the similarities between energy and cannabis sectors. Learn more about your ad choices. Visit megaphone.fm/adchoices
Dr. Kyle Kingsley is founder and CEO of Vireo Health, a publicly traded, multi-state, physician-led medical cannabis company. He's also co-author of the book Medical Cannabis Primer for Healthcare Providers. He joins Rena Sherbill to discuss cannabis as a therapeutic agent and alternative to opioids and disrupting the tobacco space. We also cover the coming influx of capital, banking reform excitement, and why the MSO space has been brutalized. Learn more about your ad choices. Visit megaphone.fm/adchoices
The latest episode of The Cannabis Investing Podcast features Dan Ahrens, manager of the newly launched AdvisorShares Pure Cannabis ETF (YOLO). With the global cannabis industry still in its infancy, Ahrens makes the case for a much more hands-on approach in managing a diversified ETF portfolio of cannabis stocks. The result is a portfolio with some real surprises - both in terms of its top holdings as well as what doesn't make the cut. Learn more about your ad choices. Visit megaphone.fm/adchoices
Vitaliy Katsenelson is Chief Investment Officer at Investment Management Associates, a Seeking Alpha contributor, as well as author of Active Value Investing and The Little Book of Sideways Markets. He joins Rena Sherbill to discuss his view on the cannabis sector as a die hard value investor, why he favors brands over growers, cigarette and alcohol companies succeeding in the sector, and why avoiding carnage is only half the victory. Learn more about your ad choices. Visit megaphone.fm/adchoices
Allan Rewak is vice president, communications and stakeholder relations at Emerald Health Therapeutics. Prior to joining Emerald, Allan was the inaugural executive director of the Cannabis Council of Canada where he played a key role in Canada legalizing cannabis. He joins Rena Sherbill to discuss whether further consolidation is ahead, how the US is unique in the cannabis world, and why investors shouldn't be overly exuberant. Learn more about your ad choices. Visit megaphone.fm/adchoices
Dooma Wendschuh is co-founder and CEO of Province Brands, a Toronto-based startup that created the world's first beer brewed from cannabis. Before entering the cannabis industry, Dooma helped develop and launch the popular Assassin's Creed franchise. He joins Rena Sherbill to discuss cannabis as a less harmful alternative to alcohol, why long term winners in the space will be in branding - not cultivation, and the new guard of cannabis companies. Learn more about your ad choices. Visit megaphone.fm/adchoices
Narbe Alexandrian is President and CEO of Canopy Rivers, the publicly traded investment platform for Canopy Growth (note that this was recorded before Bruce Linton's departure). He joins Rena Sherbill to discuss what stage we're currently at in his 5 wave theory of how the cannabis industry will evolve, why ag-tech and Europe are exciting plays right now and what investors are getting when they buy Canopy Rivers. Learn more about your ad choices. Visit megaphone.fm/adchoices
Steven Cress is Seeking Alpha's Head of Quant Strategy. He joins the show today to give listeners an idea of what Seeking Alpha's Quant Ratings and Factor Grades can provide for investors. We'll be focusing on what these ratings mean for 3 cannabis stocks: Canopy Growth, Aurora Cannabis and Khiron Life Sciences, and for the cannabis sector in general. Learn more about your ad choices. Visit megaphone.fm/adchoices
On this sneak peek episode of Let’s Talk ETFs, Seeking Alpha’s newest podcast dedicated to the burgeoning ETF space, host Jonathan Liss is joined by ExponentialsETFs CEO Phil Bak, to discuss Phil’s ‘aha’ ETF moment, after which he was hooked on ETFs for good. Tune in every Wednesday starting July 10 for full-length episodes of Let’s Talk ETFs. Subscribe now to make sure you don’t miss a single episode Learn more about your ad choices. Visit megaphone.fm/adchoices
Martin Tindall is the CEO and Director of Phoenix Life Sciences. He joins Rena Sherbill to discuss Phoenix's recently completed audits, federal deregulation, targeting diabetes treatment in the South Pacific and why branding should move away from old school imagery. Learn more about your ad choices. Visit megaphone.fm/adchoices
Lincoln Johnson is founder and CEO of EnCann Solutions, a high volume cannabis and hemp oil extraction company. He joins Rena Sherbill to discuss why cannabis is a once in a lifetime market opportunity, the unique extraction method EnCann brings to the industry, and why he thinks CBD will soon dwarf the THC market. Learn more about your ad choices. Visit megaphone.fm/adchoices
Let’s Talk ETFs is Seeking Alpha’s newest podcast. Each week, a different guest and host Jonathan Liss will take an in-depth look at a particular aspect of the rapidly evolving Exchange-Traded Fund space with a focus on how investors can best utilize ETFs to reach their investing goals. In addition, Let’s Talk ETFs will catch you up on all the most important ETF news including new fund launches and closures, top performers, and other notable ETF investing news from the previous week Learn more about your ad choices. Visit megaphone.fm/adchoices
Ted Dumbauld is COO of Curio Wellness and founder of SoNo 1420, the world’s first hemp-infused whiskey and gin distillery. Ted joined Rena Sherbill to discuss why hands on labor is not ideal for cultivation, declining alcohol sales in states where cannabis is legal, and why consolidation is here to stay. Learn more about your ad choices. Visit megaphone.fm/adchoices
Chris Naprawa is President at Khiron Life Sciences. Chris joins Rena Sherbill to discuss Khiron's focus on Latin America and beyond and its plans for growth, including partnerships and acquisitions. They also discuss global deregulation, Khiron's recent equity offerings and the benefits of having a former President on its board. Learn more about your ad choices. Visit megaphone.fm/adchoices
Marty Sumichrast is Chairman and CEO and Caryn Dunayer Co-founder and President of cbdMD, the first American NYSE traded CBD company. They join Rena Sherbill to talk about the fortuitous timing of pivoting from Level Brands into YCBD and how bad actors affect consistent implementation of the Farm Bill. They also discuss branching out into pet CBD products, major sponsorship deals and the drawbacks of great growth. Learn more about your ad choices. Visit megaphone.fm/adchoices
Brad Moore, CEO and Director of Global Cannabis Applications Corp., joins Rena Sherbill to discuss the evolution of GCAC from a technology development company to its focus today - producing better outcomes for medical cannabis patients. We also discuss the role of AI and blockchain in the sector, the difference between Canadian, US and EU regulations and the money to be made in peripheral industries. Learn more about your ad choices. Visit megaphone.fm/adchoices
Raymond Harari is the founder of Canalis Capital, a cannabis advisory company and merchant bank based in Panama, and one of the leading forces in getting Panama to legalize cannabis. He talked about this pursuit with Rena Sherbill, as well as the importance of having a long-term vision in this burgeoning industry. Learn more about your ad choices. Visit megaphone.fm/adchoices
Alan Brochstein is the founder of 420 Investor with over 20 years of experience in fixed-income and stocks, and is now focused solely on the cannabis industry. He talked with Rena Sherbill about his path to the sector, what investors should be focusing on and why most people in the industry don't actually want legalization. Learn more about your ad choices. Visit megaphone.fm/adchoices
Mark Goldhar, a member of CannaTech’s financial advisory board with vast experience as an entrepreneur and executive in the cannabis space, talked with Rena Sherbill about the future of the industry, barriers to legalization and what investors in the cannabis sector should be focused on. Learn more about your ad choices. Visit megaphone.fm/adchoices
Tahira Rehmatullah, Managing Partner of Hypur Ventures and CFO of MTech Acquisition Corp talked with Rena Sherbill about the evolution of the cannabis industry, MTech's merger with MJ Freeway, the importance of pivoting and the formality of legalization. Learn more about your ad choices. Visit megaphone.fm/adchoices
Eyal Barad, CEO Cannabics Pharmaceuticals, talked with Rena Sherbill about the business side of the company, recent volatility in the stock, its investment in Seedo, its joint venture with Wize Pharma and the patents it has in development. Learn more about your ad choices. Visit megaphone.fm/adchoices
Dr. Haleli Sharir, Principal Scientist at Cannabics Pharmaceuticals, talked with Rena Sherbill about the science driving medical innovation, the stigma of cannabis, and the goals of Cannabics going forward. Learn more about your ad choices. Visit megaphone.fm/adchoices
Meni Morim, Interim CEO and Chief Product Officer of Namaste Technologies, talked with Jonathan Liss at the CannaTech conference in Tel Aviv, where he spoke about his company's use of machine learning and AI within the Cannabis space. Learn more about your ad choices. Visit megaphone.fm/adchoices
Cam Battley, CCO of Aurora Cannabis, talked with Rena Sherbill about Aurora's place in the sector, where he sees the industry headed and if there are any blue chip cannabis stocks. Learn more about your ad choices. Visit megaphone.fm/adchoices
Yona Levy, CEO of Alvit Pharma and Director of Tefen Management Consulting, discusses the global potential in the cannabis market, Israel's role in the cannabis industry, the importance of lobbyists and doctors and what will drive global deregulation. Learn more about your ad choices. Visit megaphone.fm/adchoices
Saul discusses us with how he came to the cannabis sector, how it's grown in the 5 years he's been involved with it, emphasizes the need for cannabis companies to be nimble in this industry, what retail investors should be looking out for and what he sees as the future of the industry. Learn more about your ad choices. Visit megaphone.fm/adchoices
Introduction to Seeking Alpha's newest podcast, The Cannabis Investing Podcast. Learn more about your ad choices. Visit megaphone.fm/adchoices